Label-Free Measurements of Amyloid Formation by Suspended Microchannel Resonators by Wang, Yu
Label-Free Measurements of Amyloid
Formation by Suspended Microchannel
Resonators
Dissertation




der Georg-August University School of Science (GAUSS)
vorgelegt von
Yu Wang
aus Shanxi, V. R. China
Göttingen, 2013
Betreuungsausschuss
Dr. Thomas P. Burg, Biologische Mikro- and Nanotechnologie, Max-Planck-Institut
für Biophysikalische Chemie
Prof. Dr. Christoph F. Schmidt, Molekulare und Zelluläre Biophysik, Universität
Göttingen - Drittes Physikalisches Institut - Biophysik
Mitglieder der Prüfungskommission
Referent: Prof. Dr. Christoph F. Schmidt, Molekulare und Zelluläre Biophysik,
Universität Göttingen - Drittes Physikalisches Institut - Biophysik
Korreferent: Dr. Thomas P. Burg, Biologische Mikro- and Nanotechnologie,
Max-Planck-Institut für Biophysikalische Chemie
Weitere Mitglieder der Prüfungskommission:
Prof. Dr. Markus Zweckstetter, Proteinstrukturbestimmung Mittels NMR, Max-
Planck-Institut für Biophysikalische Chemie
Prof. Dr. Sarah Köster, Nanoscale Imaging of Cellular Dynamics, Universität
Göttingen - Institut für Röntgenphysik
Prof. Dr. Tiago Fleming Outeiro, Neurodegeneration und Neurorestaurations-
forschung, Universitätsmedizin Göttingen
Prof. Dr. Peter Jomo Walla, Biomolekulare Spektroskopie und Einzelmolekül-
detektion, Max-Planck-Institut für Biophysikalische Chemie




Amyloid deposition in tissues is a hallmark of many severe diseases including
Alzheimer’s and Parkinson’s disease. The formation of amyloid fibrils involves
several intermediate steps, and revealing the kinetics of each step is of great
importance for a deeper understanding of the underlying mechanisms. However,
conventional colorimetric or fluorescent assays, such as Thioflavin T, are not well
suited for precise measurements of aggregation kinetics, as these dyes are only
sensitive to specific states of the aggregation and their binding may interfere with
the process. Biosensor techniques are superior in this regard since the measurement
is label-free. However, established methods such as Surface Plasmon Resonance
(SPR) and Quarz Crystal Microbalance (QCM) have several limitations, including
large sample consumption, low sensitivity, and complex data analysis. This thesis
presents, for the first time, the label-free kinetic measurement of amyloid formation
by mass using Suspended Microchannel Resonators (SMR). SMR devices achieve
low sample consumption at high mass resolution and provide a direct readout of the
buoyant mass of aggregates.
As a prerequisite for quantitative measurements of amyloid elongation kinetics
by SMR, a new method for the reliable immobilization of seed fibrils inside the
device was first established. The method allowed the reproducible deposition of
ensembles of insulin amyloid fibrils inside the 3 µm tall detector channels without
clogging. To this end, a robust vapor-based method for the deposition of aminosilane
layers in closed microfluidic systems has been developed, and a novel quantitative
fluorescence imaging method was introduced to optimize the density, quality and
stability of these layers in situ.
In the surface-based SMR measurements, the reproducible seed fibril
immobilization has been confirmed by having consistent surface fibril density of
734 ± 89 molecules/µm2. After prevention of non-specific protein adsorption and
validation of the stability, the fibril elongation rates and the absolute rate constants
can be readily determined. For 1 mg/mL monomer concentration, the results show
that the binding of a monomer to a fibril occurs every 4.9 ± 0.5 s, corresponding
to the rate constant of (1.2 ± 0.1) × 103 M−1 s−1 at 37 ◦C. Further on-rate
V
VI
measurements depending on monomer concentration and temperature provide in-
sights into the mechanism and thermodynamics of the process. A two-step "dock-
lock" elongation model fits well with the measurements. The determined enthalpy
and the entropic contribution of the activation are in agreement with literature
data and indicate in general an enthalpically unfavorable but entropically favorable
process.
In the last part of the thesis, effects of shear flow and additives such as metal
ion salts, natural products and small organic compounds, have been studied by
measuring the fibril elongation rates. In contrast, dissociation experiments using the
surface-based SMR technique have been applied to monitor the degradation of the
immobilized fibrils. Both approaches are demonstrated to be promising platforms
for screening potential inhibitors and therapeutic drugs for amyloid-related diseases.
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Amyloid formation is the hallmark of over 40 human diseases and arises from
abnormal protein aggregation [65]. Novel techniques are urgently required to
comprehensively understand the kinetics, mechanisms and energy landscape of the
process. This chapter focuses first on the biological background (the significance,
properties, mechanism hypothesis and energy aspect) of protein aggregation and
amyloid fibrils in Section 1.1. In Section 1.2, detection techniques, in particular
the surface-based methods to study amyloid fibril formation, are reviewed, and the
significance of developing novel techniques is discussed to address current technical
limitations. At the end of this chapter (Section 1.3), the motivation and aim of this
thesis are presented.
1.1 Protein Aggregation and Amyloid Fibrils
Protein aggregation is a ubiquitous process of molecular self-assembly in
biology [267]. Abnormal protein misfolding may lead to amyloid formation.
Tissue deposits of such highly fibrous structured protein aggregates have been
reported to be a pathological feature of a large number of human and animal
diseases as shown in Table 1.1 [23,65,86,102,103,137,139,176,211,220,233,239,245].
These include two of the most common neurodegenerative disorders in the aging
population — Alzheimer’s and Parkinson’s disease, and other diseases caused by
local or systemic amyloidosis such as localized amyloidosis at the place of repeated
insulin injection. The prevalence of such diseases is still steadily increasing and is
expected to double by the middle of the century [27,229].
Amyloid fibrils have been recognized as the pathologic signs since the early
1850s, and major advances in understanding amyloid formation as the key feature
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Neurodegenerative Alzheimer’s disease(AD) Aβ(1-42), Tau
diseases Parkinson’s disease (PD) α-synuclein
Prion diseases (e.g. TSE) Prion
Huntington’s disease (HD) Huntingtin
Serpinopathies Neuroserpin
Progressive supranuclear palsy Tau
(PSP) Heat shock proteins
Spinocerebellar ataxias (SCA) Tau, Ataxins
Systemic Diabetes type II Amylin
amyloidosis Haemodialysis related A β-2 Microglobulin
Cystic fibrosis CFTR protein
Localized Injection Amyloidosis Insulin
amyloidosis Aging pituitary Prolactin
Conea Lactoferrin
Animal amyloidosis Mammary gland (Cow) α-S2C casein
Age-related disease (Dog) Apolipoprotein AI
Plasmocytoma (Cat, Horse) Immunoglobulin
of many diseases have been achieved in the last 40–50 years, [95,136,233]. However,
the complicated processes of amyloid formation are still poorly understood so
far. Diverse proteins of different size, function and sequence polymerize into
unbranched fibrils with similar ultrastructural properties and appearance (Figure
1.1) [23,195,245].
Recent studies show that amyloid fibrils can be obtained in vitro from proteins
that are exposed to extreme conditions, e.g. low pH, chemical or heat denatu-
ration [4, 23, 24, 41, 65, 87]. This leads to the conclusion that amyloid fibrils are
possibly a common state of proteins and their formation limits the production
and use of proteins in a wide range of pharmaceutical and biotechnological
applications. Conversely, experiments to study amyloid formation can be carried
out in vitro and may lead to more comprehensive understanding of the process. In
the following sections, previous studies and hypothesis on amyloid structure and
formation mechanism will be reviewed and the reported development of therapies
for neurodegenerative diseases are summarized.
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Figure 1.1: Amyloid fibril formation from diverse proteins. Images of proteins and fibrils
are adapted from Protein Data Bank (PDB) and the reference [245].
1.1.1 Structure, Characteristics and Properties
The structural understanding of amyloids has advanced with available technologies.
Divry and Florkin in the 1920s first reported the tinctorial property of amyloid
fibrils by showing the apple green birefringence of the fibrils when stained with
Congo Red dyes and observed under polarized light [195]. Because the Congo
Red staining assay has later been proved to show false positive response in some
cases [131, 155], the fluorescent property with Thioflavin T (ThT) assay has been
widely applied to indicate the presence of amyloid formation in vitro (Section 1.2).
The ultrastructure of amyloid fibrils was first defined crystallographically with
X-ray diffraction studies in the late 1960s [38, 70, 87, 245]. The X-ray pattern
shows that one of the principle features of amyloids is pleated cross-β sheets with
ca. 4.7 Å inter-chain spacing and ca. 10–11 Å inter-strand spacing, as shown in
Figure 1.2. The β-sheet strands are aligned perpendicular to the long axis of
the fibrils. Circular dichroism spectroscopy (CD), cryo-electron microscopy [120]
and nuclear magnetic resonance (NMR) [78, 213, 243] also confirm the existence
of the β-sheet structure in mature amyloid fibrils and protofibrils. As depicted in
Figure 1.2, β-strands of LVEALYL peptide have been suggested to be the main
contributor to the spine formation of insulin fibrils [116]. The pair structure shows
the packaged atomic structure as a result of steric zipper interaction. The steric
zipper interface is typical for amyloid formation, since similar structures have been
reported with several other amyloid fibrils [102,183,243]. Most β-sheet structures of
amyloid fibrils have a right-handed twist of 0–30◦ between neighbouring β-strands.
The twisting around a common helical axis accounts for the repeating unit of
ca. 115 Å (1.1) [245]. It has been demonstrated that this helical structure enables
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formation of hydrogen bonding between the β-strands and thereby enhances the
rigidity and stability of amyloids [184]. Some studies have shown that amyloid
fibrils are even highly resistant to proteases [193, 228]. Electron micrographs show
that all amyloid fibrils consist of individual protofibrils of 40–100 Å in width and
indeterminate in length, which may aggregate laterally to mature fibrils of up to
300 Å in width [70,76,233,256].
Figure 1.2: Schematics of β-strand pair formed by LVEALYL peptide, the association of
protofibrils to mature fibrils and a classical X-ray diffraction pattern of cross-β spine with
4.7–4.8 Å meridional and 10–11 Å equatorial reflections. The view of the peptide β-strand
pair as a result of steric zipper interaction is shown perpendicular to the fibril axis. The
figure is adapted and partially modified from the references [168] and [116].
In order to elucidate basic properties of amyloid fibrils such as compactness,
fluctuation, cavities and hydration, Akasaka et al. performed studies using a
density meter and an ultrasonic velocity meter combined with CD on a solution
of amyloid fibrils of hen lysozyme [3]. They concluded that the transition from a
monomer into a protofibril can result in a large increase in partial specific volume
of ca. 570 mL/mol and in partial specific adiabatic compressibility coefficient of
8.83 x 10−12 cm2/dyn−1. The high voluminous and compressible properties imply a
cavity-rich, fluctuating nature of the amyloid protofibrils, which is in line with the
above described β-strand spacing of the fibrils.
Mechanical properties of individual amyloid fibrils have also been studied with
insulin fibrils as a model system using atomic force microscopy (AFM) [137, 235].
The strength of the fibrils has been characterized to be 0.6 ± 0.4 GPa, comparable
to that of steel (0.6–1.8 GPa); and the mechanical stiffness has been measured to
be 3.3 ± 0.4 GPa by AFM, comparable to that of silk (1–10 GPa). Interestingly,
it has been discovered in nature that many insect silks, such as chrysopa fibres and
spider silk, give a fibrous, cross-beta diagram in their natural state [87,137,225,235].
1.1. PROTEIN AGGREGATION AND AMYLOID FIBRILS 5
1.1.2 Kinetics, Mechanisms and Energy Landscape
It has been widely accepted that amyloid fibril formation consists of many
intermediate steps, yet the underlying mechanisms are still poorly understood.
Comprehensive kinetic studies can provide opportunities to establish mechanistic
models for the amyloid formation process. However, precise evaluation of the growth
rates is challenging in bulk solution due to the complexity of many intermediate
states involved and due to limitations of current detection techniques. In general, it
is very challenging to establish models or rate equations to represent the nonlinear
complex nature of the amyloid formation process. Progress, however, has been
made in the development of detection techniques over the last 30–40 years.
Eaton, Ferrone, Hofrichter and coworkers introduced in the 1980s that
heterogenous nucleation and filament fragmentation do occur during the
hemoglobin S aggregation. Kinetic measurements using the fluorometric ThT
method in solution also suggest a nucleation-dependent polymerization as depicted
in Figure 1.3 [136, 239]. In the suggested description, there is a slow lag phase
during the transition from monomers to structured aggregates (nulei). This is
a critical rate-limiting step for amyloid formation [195]. Once the nuclei are
formed, they elongate rapidly to form larger protofibrils and fibrils. The lag
phase can be eliminated by addition of pre-formed nuclei or short fibrils to
protofibrils. This process is known as the seeding effect [54, 66, 134]. Further-
more, amyloid protofibrils can assemble into mature fibrils by fibril-fibril association.
Based on kinetic studies, a number of models for amyloid formation have been
proposed, as reviewed by Zerovnik et al. and Kelly et al. [127, 276]. Some popular
models are listed below.
Template assisted (TA) model. In a rapid pre-equilibrium step, a soluble pep-
tide in a random coil loosely binds to a pre-assembled nucleus. Then a rate
determining structural change occurs to stabilize the peptide to fibril end.
Nucleated polymerization (NP) model. The rate-limiting step is the forma-
tion of a nucleus from an equilibrium including monomers that are or are not
able to assemble. Once a nucleus is established, rapid assembly occurs by
adding assembly competent monomers to the nucleus.
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Figure 1.3: Nucleation-dependent polymerization model of amyloid aggregation, taken
from Kumar et al. [143].
Monomer-derived conversion (MDC) model. In the rate-determining step, a
monomer with a conformation in fibril-like state can associate with a monomer
in the native state to form a dimer in fibril-analog state. After the dimer
dissociation, both monomers in fibril-analog state rapidly bind to the ends of
growing fibrils.
Nucleated conformational conversion (NCC) model. Monomers first accu-
mulate to oligomers without conformational conversion. Association of the
oligomers into nuclei with conformational conversion then takes place as the
rate-determining step.
Off-pathway folding (OFF) model. In a parallel process to the on-pathway, by
which structured oligomers are formed, irreversible amorphous intermediates
and their domain-swapped dimers can be partially formed. Protofibril for-
mation then takes place by end-to-end elongation of the intermediates. The
protofibrils undergo further lateral and end-to-end association to form fibils.
It is difficult to judge which of the models best describes the general
process of amyloid formation. It is also possible that several mechanisms
fit various specific cases. Experimental evidence has also been reported to
show diverse pathways in individual amyloid formation processes with different
proteins [45, 66, 86, 90, 96, 118, 127]. A more comprehensive schematic including
the possible pathways has been illustrated by Jahn and coworkers in Figure 1.4.
Here, structured oligomeric nuclei can be formed either via partially unfolding
of intermediates or via partial structuring of native or disordered aggregates. In
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addition, different amyloid-forming proteins sometimes show diversity with regard
to oligomer formation following diverse possible mechanisms including domain
swapping (ds), edge-edge-association (ee), strand association (sa) or β-strand
stacking (bs) [66,102], but they all convert into fibril seeds with the regular cross-β
secondary structure. Finally, similar as presented in Figure 1.3, the transition from
oligomeric species to protofibrils and to further mature fibrils takes place through
lateral association accompanied by some degree of structural reorganization [98].
In equilibrium, pathways such as monomer-dependent primary nucleation, filament
fragmentation as secondary nucleation and secondary nucleation pathways are
suggested to be responsible for the increase in the number of the nulei [53, 143].
Figure 1.4: Amyloid fibril pathways in the case of lysozyme formation. Modified images
adapted from Jahn et al. [90, 118].
So far, the most significant achievement in kinetic measurements of the amyloid
formation has been made in elongation processes, by which the sizes of existing
aggregates increase rapidly. Early kinetic studies revealed a first-order dependence
on the monomer and fibril concentrations, suggesting a bimolecular mechanism of
growth by monomer attaching to the ends of fibrils. Recent kinetic measurements
indicate a dock-lock-mechanism to be a general elongation process of amyloid
fibrils [39,74,92,138,169]. The dock-step is described as attachment of monomers to
fibril ends, while the lock-step is described as irreversible conversion of monomers
to fibril ends due to conformational rearrangement. Despite the agreement with
the dock-lock-mechanism as a general model for amyloid elongation, differences
exist in the detailed steps based on the experimental data measured with individual
methods. Esler et al. and Cannon et al. both measured the elongation of Aβ
fibrils [39,74]. Using radioactive labeling of Aβ fibrils immobilized in 96 well plates,
the measurements by Esler [74] suggested a two-step reaction model as depicted
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in Figure 1.5. The model includes a reversible dock process with dissociation
of ca. 10 minutes half-life and an irreversible lock phase with dissociation of
ca. 1000 minutes. In contrast, Cannon and coworkers found that a two-step model
cannot sufficiently fit their kinetic data obtained by surface plasmon resonance
(SPR) [39]. Instead, they proposed the results for a three-step model, by which an
additional maturation step was introduced after the attachment step (dock) and
the conformational rearrangement step (lock). Again, it is hard to judge which of
both models best describes the actual process.
Figure 1.5: A model of dock-lock mechanism representing amyloid elongation in
biosensor-based systems, taken from Esler et al. [74].
The dissociation processes lead to aggregate degradation or fragmentation,
and therefore play significant role in molecular recycling [41, 53]. In general, fibril
dissociation is not usually observed, since the process is much slower than the
aggregation growth that actually occurs. Due to the potential significance of
amyloid dissociation for drug development, measurements of dissociation kinetics
under different conditions were conducted as part of this thesis.
Amyloid formation has recently been interpreted as a consequence of changes
in free-energy [14, 31, 45, 52, 118, 169, 172], as graphically depicted in Figure
1.6 [104, 252]. The y-axis is a measure of the free energy and the x-axis is
a coordinate of various molecule conformations that successively exist during
amyloid formation. The funnel-shaped energy landscape indicates the preferred
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conformations under given conditions by following the "down-hill" path. Generally,
the nucleus formation from native monomers to oligomers is thermodynamically
unfavourable. Native and metastable non-native intermediates are possibly present
during the folding process due to the ruggedness of the landscape. Compared
to the unfolded state, the partially folded states or misfolded states are both
thermodynamically and kinetically more readily accessible and may therefore
represent a key precursor to protein aggregation. Therefore, they often tend to
aggregate due to the formed hydrophobic forces when hydrophobic amino acid
residues and regions of unstructured polypeptide backbones are exposed. Driven by
intermolecular interactions, amorphous aggregates that lack long-range order form
predominantly. Alternatively, aggregation can lead to the formation of ordered,
fibrillar oligomers as seeds. The subsequent elongation is highly favourable and
proceeds rapidly to the fibril structure.
Figure 1.6: Schematics of energy landscape of protein folding and aggregation, taken from
Vabulas et al. [252]. The light blue surface shows the possible conformations following the
down-hill path due to the intramolecular contacts, and the dark blue surface shows the
energy-favored states due to intermolecular contacts.
There is evidence that most of the protein mutations and denaturation
associated with amyloid formation can result in a higher equilibrium population
of the non-native unfolded and partially unfolded states. The cause could be a
decrease in the conformational stability of the native fold [45]. In the presence
of chaperons, the monomers can be more populated and stabilized as a result
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of the increase in free energy of activation from the native state to the unfolded
state [30, 52,104].
1.1.3 Diagnosis and Inhibition of Neurodegenerative Diseases
Early diagnosis of neurodegenerative diseases and other amyloid-related diseases
are of great importance. Until 1988, the only practical diagnosis of amyloidosis
made use of the Congo Red staining assay. Later on, the use of radiolabelled serum
amyloid P component (SAP) was developed into a routine tool in clinical practice
as a specific, quantitative in vivo tracer for amyloid deposits, as SAP has been
suggested to exist in amyloid deposits and undergoes specific calcium-dependent
binding to amyloid fibrils [206]. The ThT assay has subsequently been introduced as
diagnostic method for the diseases. In the more recent past, conformation-sensitive
antibodies started to be used for diagnosis of neurodegenerative diseases [101].
Current clinical treatment of amyloidosis comprises maintenance of organ
function, dialysis or transplantation and control of responsible conditions for
production of fibril precursors [206]. Elimination of the supply of precursor proteins
leads to regression of amyloid deposits. Based on the understanding of the amyloid
formation mechanisms, new approaches under development are being directed
towards achieving one of the following goals as illustrated in Figure 1.7 [52,102]:
Stabilization of the native folded structure. The native monomers can be
bound with proteins or small molecules to prevent unfolding and aggregation.
Inhibition or interference of steps related to conformational change.
This strategy is to introduce binding molecules to individual steps to
inhibit nucleation and elongation processes or to direct the paths towards
non-amyloid products. The steps including formation of amyloid structured
oligomers, protofibrils and also mature fibrils are involved here.
Clearance or degradation of neurotoxic species or amyloid fibrils.
Recently, structured oligomeric nuclei have been considered to be the
primary cytotoxic species for neurodegenerative diseases [57, 223, 243], but
whether amyloid fibril deposition itself may be a protective process is still
under debate. Nonetheless, it is noteworthy that, during the therapy develop-
ment, care needs to be taken not only to the effects of mature amyloid fibrils
but also to that of the protofibrils and the neurotoxic oligomers.
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Figure 1.7: Schematic illustration of strategies to inhibit amyloid formation, taken from
Hard et al. [102]. (a)–(e) Possible mechanisms by ligand binding leading to non-amyloid
species. (a) Stabilization of monomers in native states. (b) Sequestering of monomeric
peptide. (c) Off-pathway to non-toxic oligomers. (d) Off-pathway to terminate fibril
elongation. (e) Disassembly of amyloid fibrils. (f) Refolding backwards to native monomer
state. (g) Clearance of amyloid-related species.
Substantial effort has been given to find or develop drugs that accomplish
the tasks above. Many species that inhibit the in vitro amyloid formation have
been explored and tested using diverse biophysical techniques, although further
evaluation of the candidates for therapeutic purposes is necessary. Some of the
important candidates for which great therapeutic potential has been reported are
summarized and listed in Table 1.2. They are categorized by six inhibition strategies:
Small aromatic molecules. Currently, many small aromatic molecules are sug-
gested to be potential candidates for inhibition of amyloid formation. This
class of molecules was shown to inhibit the amyloid fibril growth, possibly
because their binding can stabilize the protein or in some cases alter the mor-
phology of amyloid fibrils [158].
Small peptides or proteins. Short peptides, proteins and antibodies have been
reported to achieve efficient inhibition of amyloid formation by specifically
binding to a particular conformation of intermediates or protofibrils [86, 101].
However, serious side effects have been shown to take place [2].
Chaperones. Chaperones have been proposed to stabilize misfolded proteins by
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Table 1.2: Inhibitors reported for neurodegenerative diseases.
Category Inhibitor Protein
Small aromatic molecules Benzene, 1-naphthol, Insulin
Epigallocatechin gallate [158,279]
Congo Red, ThT [32] Aβ
Metalloporphyrins [202,231] Insulin, Aβ, τ
Naphthalene-derivates [158] Insulin
A julolidine aldehyde [59] Aβ
Methylene blue [198] Aβ, τ
PcTS [5,217] Aβ, αS, τ
Small peptides/proteins B10AP [101] Aβ
ZAβ3 Affibody [102] Aβ
Chaperones/Proteases β-/γ-secretase [2, 52, 103] Aβ
Clusterin, SAP [268] Aβ, αS
sHsp αB-Crystallin [138,260] αS, Insulin
Chemical chaperone TMAO [138] Insulin
Metal ions Cu2+, Zn2+ [103,192] Aβ, Glucagon
Natural products Ectoine, Betaine, Insulin, Hutingtin
Trahalose, Citrulline [9]
Carbohydrates Heparin [89] Insulin
Dextrose, Emdex [124] Insulin
binding to them followed by guiding their degradation. However, care must be
taken here since chaperones can in some cases also promote amyloid formation
[268].
Metal ions. Metal ions have been suggested to prevent amyloid formation by
coordinating to the native monomers, and therefore serve as co-factors in
modulating the amyloid formation. The strategy has been used for Aβ fibril
inhibition and has now been reached the clinical trial stage [102].
Natural products. Some stress-induced molecules, such as ectoine, trahalose, be-
taine and citrulline, are accumulated in many microorganisms for surviving
against external stress. These natural products show their ability to prevent
abnormal protein folding at high concentrations (ca. 500 mM) due to increased
protein stability [9].
Carbohydrates. Some carbohydrates have been reported to suppress protein ag-
gregation into fibrils. Heparin, for example, has been proposed to bind to the
positive domain of insulin as a strong polyanion and thereby to inhibit the
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electrostatic interaction within proteins [89].
1.2 Detection Techniques for Amyloid Formation
Techniques to detect and analyse amyloid formation are important for gaining in-
sight into the amyloid characteristics, mechanistic and thermodynamic information
introduced in Section 1.1.1 and Section 1.1.2. The most widely applied in vitro and
in vivo technologies [6, 14, 27, 30, 138, 189, 205, 259] are summarized in Table 1.3.
Only in vitro technologies are described in detail as follows.
Techniques to reveal structure
X-ray crystallography is used to determine amyloid structures of various states.
The limitation is that proteins need to be crystallized prior to the detection [205].
Nuclear magnetic resonance spectroscopy (NMR) [41, 111, 210, 217] is a powerful
spectroscopic technique to probe structures of species in protein aggregation
pathways. Furthermore, NMR relaxation can be used to study dynamics of
the aggregation events. In contrast to X-ray crystallography, crystallization is
not necessary using this method. The conformational changes accompanying
protein aggregation can also be detected using circular dichroism spectroscopy
(CD) [8, 123, 128], infrared spectroscopy (IR) and Raman spectroscopy [8, 14, 261]
by revealing the protein secondary structures. In mass spectrometry, molecules are
fragmented as molecular ions based on the mass-to-charge ratios [148, 215]. Both
mass spectrometry and NMR spectroscopy can measure dynamics of conformational
fluctuations in proteins by conducting hydrogen-deuterium exchange experiments.
The kinetic measurements using the mass spectrometry, CD, IR and Raman spec-
troscopy allow relative quantification, but cannot measure absolute rate constants
of conformational changes.
Techniques to detect morphology
Separation methods including electrophoresis [212] and size exclusion
chromatography (SEC) [230] are able to measure the size and mass distribution
of molecules during amyloid formation. A significant limitation of these methods
lies in the equilibrium disturbance during the separation, causing uncertainty and
complexity in data analysis. The problem arises also in molecular-weight-dependent
sedimentation and analytical ultracentrifugation (AUC) [205], which measures the
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change of mass distribution in amyloid formation processes.
In contrast, light scattering [146, 230] or dynamic light scattering (DLS) [214]
are more straightforward spectroscopic methods to observe the size distribution
of the amyloid aggregates in different states. These label-free methods measure
the hydrodynamic radius from 1 nm up to 4 µm by detecting the fluctuations of
the scattered light intensity. The fluctuations provide a measure of the molecular
diffusion coefficient, which depends on the size and shape of the molecules.
The main drawback of the detection system is sensitivity to large aggregates or
impurities [27, 230]. Furthermore, fibril-fibril interactions in solution may also lead
to overestimation of the fibril size by slowing down diffusion. Finally, data analysis
based on the autocorrelation function and interpretation can be quite complex and
challenging with polydisperse samples.
The size distribution and molecular morphology can also be detected using ultra-
structural methods with high resolution (subnanometer to nanomter scale). Electron
microscopy (EM) has often been applied to long, unbranched fibrils. However, the
method cannot be readily applied to monitor in situ amyloid growth, as heavy metal
staining and drying of the samples is required prior to the detection [43,205].
The 3D-structure (topography) of amyloid aggregates can be directly visualized
in the ambient environment by atomic force microscopy (AFM) [1, 130, 171, 272].
The specimens are placed on an even surface and scanned with a cantilever with
a nanometer radius-of-curvature-sized tip under piezoelectrical control. AFM
detection provides height information with subnanometer resolution by recording
the cantilever deflections in an optical lever system. Recently, time-lapse AFM
studies have been carried out to study aggregate growth, and the method will be





















Table 1.3: Techniques applied for amyloid formation.
Method Characteristic Comment
In vitro assays
X-ray crystallography Structure Crystallization required; Limitation of size inhomogeneity.
CD spectroscopy Secondary structure Label-free; Relative quantification; Large sample amount.
NMR spectroscopy Structure & dynamics Label-free.
Mass spectrometry Structure & Kinetics Relative quantification.
IR and Raman spectroscopy Structure Relative quantification.
TEM microscopy Size & Morphology Quantitative analysis challenging; Sample dried and at-
tached to a solid support.
AFM microscopy Size & Morphology & Kinetics Label-free; Low throughput; Sample attached to a solid
support.
SEC Size & Shape Lengthy experiment; Equilibrium disturbance.
AUC Molecular weight Large sample amount.
Light scattering Size Label-free; Low sensitivity to aggregation forms.
DLS Size & Kinetics Label-free; Labor intensive; Low sensitivity to aggregation
forms.
Electrophoresis Size & Shape & Charge Solubility required; Equilibrium disturbance.
In situ ThT assay, TIRFM Fluorescence & Kinetics Interaction of ThT with aggregates.
Ex situ ThT assay Fluorescence & Kinetics More labor-intensive; Artifacts disturbance.
SPR Mass & Kinetics Label-free biosensor; Surface-bound detection.
QCM Mass & Kinetics Label-free biosensor; Surface-bound detection.
In vivo assays
MTT assay Cell death Lengthy experiments
Immunohistochemistry Aggregate amount & Location Specific antibodies required.
ELISA assay Aggregate levels Specific antibodies required.
Genetic screening Pathological pathways Lengthy experiment.
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Techniques to monitor kinetics
Many techniques to measure kinetics of amyloid growth are performed in bulk
solutions. Traditional methods rely on staining with dyes such as Congo Red, ANS
or ThT. Binding of such dyes to the amyloid fibrils changes their spectral properties
and can thereby be detected with optical spectroscopic methods [11,20,129,178,219].
Currently, the fluorescence-based ThT assay is widely applied as a gold standard
to measure the kinetics of amyloid formation. Figure 1.3 shows a typical time
course of amyloid growth detected by ThT. However, these dyes are insensitive
to oligomers and other early aggregation species. Furthermore, dyes are very
likely to interfere with the aggregation process. For example, Congo Red has
already been suggested to inhibit in vivo amyloid formation [155, 276] in certain
environments. ThT has also been reported to interfere with the amyloid formation
during binding with the fibrils and the measured signals can be biased [32,115,192].
Further problems include indeterminate binding stoichiometry and the insensitivity
to oligomeric intermediates. In general, quantitative kinetic measurements in
solution are challenging due to the inaccuracy of the exact concentrations of the
species [20,265].
Recently, much effort has consequently been directed towards developing
quantitative surface-based detection techniques, which allow real-time monitoring
of fibril growth in the elongation phase. The most significant methods reported
to detect the process are in situ AFM, TIRFM, QCM and SPR. Schematics of
the working principles and the characteristic growth curves are summarized and
depicted in Figure 1.8. In all four approaches, seed fibrils are immobilized on the
surface of the detection systems prior to the exposure to the monomer solutions.
In situ AFM. AFM experiments in liquid enable time-lapse measurements of
biological samples in the aqueous environment. The specimens are fixed here
on the substrate surface and the cantilever tip maps the height of the surface
using tapping mode. The scan speed is several seconds or minutes per frame.
The approach has been recently reported to monitor the in situ growth of
amylin protofibrils, as shown in Figure 1.8 (b), and fibrils formed with specific
heptapeptides [1, 97].
TIRFM. Total internal reflection microscopy uses an evanescent wave, generated
by the total internal reflection of the incident light at the solid-liquid-interface,
to selectively illuminate and excite fluorophores of the specimens in a restricted
region adjacent to the interface. The evanescent electromagnetic field decays
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exponentially from the interface and penetrates to a depth of a few hundred
nanometers into the medium. TIRFM has been applied to monitor amyloid
elongation combined with ThT-staining assay. As shown in Figure 1.8 (a), Ban
et al. observed a unidirectional length increase of β2-m and Aβ seed fibrils lying
in parallel with the slide glass surface, since the evanescent field formed by the
total internal reflection of laser light penetrates to a depth of 150 nm [11,12].
QCM. QCM monitors the resonance frequency of surface shear waves on the sen-
sor [31, 138, 265]. The rate of the frequency shift is proportional to the rate
of mass change on the quartz crystal surface. In addition to the frequency
measurements, the dissipation is often measured to quantify the damping in
the system, as applied in the QCM-D detection system. The chamber volume
above the sensor is 5–50 µL and the minimum volume required for one sam-
ple injection is 30–150 µL. The mass sensitivity in liquid can be 0.5–2 ng/cm2.
Typical flow rates are in the range of 50–200 µL/minutes. Knowles et al. deter-
mined the elongation rates of bovine insulin fibrils by measuring the increase
in hydrodynamic mass bound to the quartz crystal, as shown in Figure 1.8 (c).
SPR. In SPR measurements, a polarized incident light beam excites the oscillation
of electrons at the interface of metal and an aqueous solution [265]. When the
frequency of photons of the incident light matches the natural frequency of
the surface electrons, resonance takes place. At a specific incident angle, the
intensity of the reflected light is reduced due to the energy transfer from the
incident wave to surface plasmons. The resonance condition of SPR measure-
ments is sensitive to the materials adsorbed onto the chip surface. The SPR
signal, expressed in resonance units, is a measure of refractive index and thus
of mass concentration within ca. 300 nm of a sensor chip surface. This implies
that the approach can detect the growth of the immobilized amyloid fibrils less
than 300 nm from the surface. The SPR signal increases when the immobilized
fibrils (e.g. Aβ in Figure 1.8 (d)) grow in the presence of monomer solutions
and decreases when the fibrils degrade [39,105].
Among these methods, in situ AFM [12, 21, 113] monitors the growth by length
directly and TIRFM monitors the growth by length using ThT-assay. Moreover,
biosensor-based methods, QCM [30, 31, 138, 196] and SPR [39, 105, 241] have
been developed and applied as label-free techniques, that are sensitive to mass
change on the biosensor surfaces as a consequence of the growth or degradation
of the immobilized surface fibrils. These label-free biosensor methods have several
advantages over conventional in-solution assays and have therefore gained increasing
interest for the last several years [265]. First, small differences in elongation rates
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due to subtle variations in the reaction conditions can be resolved quantitatively
in real-time. Second, the system allows probing the growth of a defined ensemble
of fibrils repeatedly under various conditions simply by replacing the monomer
solutions. Finally, both continuous flow cell systems keep concentrations constant
over extended reaction times. Additionally, these platforms also allow the influence
of disparate conditions and additives on the kinetics of amyloid formation to be
studied quantitatively. So far, biosensor-based detection systems are still under
development. However, both QCM and SPR are limited in terms of their potential
for further miniaturization.
Figure 1.8: Working principles and the characteristic signals of the most significant
surface-based techniques [(a) TIRFM (adapted from Ref. [11] and [12]), (b) AFM (adapted
from Ref. [1]), (c) QCM (adapted from Ref. [138]) and (d) SPR (adapted from Ref. [265]]
to study real-time amyloid fibril growth.
1.3 Motivation and Aim of the Thesis
The primary aim of this study is to develop a new surface-based approach with
Suspended Microchannel Resonators (SMR) for precise online kinetic measurements
of amyloid formation.
The SMR method measures the resonance frequency of a micromechanical
resonator, that encloses a microchannel of 3 × 8 µm (Figure 1.9), and the frequency
shift is correlated to changes of the resonator mass. The accuracy of the label-free
approach relies on the high sensitivity of the resonance frequency of the SMR
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system to mass [34]. More details of the SMR technique and its characteristics are
presented in the Theory chapter (Section 2.1.1).
Figure 1.9: Working principle (adapted from Ref. [34] and [33]) and illustrated
characteristic signals of amyloid growth detected by SMR (presented in the Kinetic Mea-
surements chapter).
Although the resolution of the promising microfluidic transducer system is as
high as 10−15 g in solution, the mass change induced by single monomeric proteins
can still not be detected. The buoyant mass of insulin (51 AA), αS (140 AA) and
Aβ (42 AA) are all in the zeptogram range, which is over six orders of magnitude
below the mass resolution of the SMR devices used in this work. In order to reveal
kinetic and thermodynamic parameters governing the elongation phase of amyloid
growth, the strategy has to be directed to the growth monitoring of a quantity of
preformed seed fibrils that are immobilized on the inner walls of the microchannels.
The fibril growth rates of the surface seed fibrils are then measured when monomer
solutions flow through the microchannels.
The surface-based SMR method is presented here to be an alternative approach
to the most currently reported biosensor techniques, but achieves additionally
further miniaturization of the devices with higher mass resolution.
Compared to the conventional methods discussed in Section 1.2, the SMR
approach has the following advantages:
• This label-free method is sensitive to all states of the aggregation and avoids
the risk of interfering with the aggregation reaction.
• SMR enables in situ and real-time quantitative measurements of kinetics with
high accuracy.
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• The surface-bound detection system allows successive measurements on a
defined ensemble of molecules.
• The elongation detection of the immobilized fibrils is insensitive to the distance
from the surface.
• The microfluidic system allows changing reaction conditions quickly and
reliably by replacing the solutions in microchannels. This provides the
practical benefit of high sample throughput.
• The detection with the miniaturized devices can be performed within minutes
with sample consumption as low as several tens of microliters.
Compared to SPR and QCM with sensor dimensions in the millimeter range,
the surface-based SMR approach with the resonator microchannel of ca. 5.6 pL
allows measurements with low sample consumption over a large time scale from
seconds to hours. Furthermore, in the surface-based SMR measurements, mass
resolution approaches 0.01 ng/cm2 and is still being optimized. In contrast, the
mass resolution is ca. 0.5–2 ng/cm2 in QCM measurements and ca. 0.05 ng/cm2 in
SPR measurements.
Reliable immobilization of seed fibrils onto the inner walls of SMR microchannels
is among the most important prerequisites for the measurement. However, this
task is challenging in such microchannels of micrometer dimensions. First,
contaminations need to be strictly eliminated, since they can easily clog the
microchannels. Thereafter, the inaccessibility of the surfaces increases the difficulty
of performing multi-step protein immobilization inside the microchannels. Finally,
evaluation methods for the microchannel functionalization and immobilization need
to be developed, since the microchannels of SMR devices in this work are neither
accessible to surface analytical tools nor visible.
The scientific objectives of the dissertation comprise three parts as follows:
Development of methods for surface functionalization and protein
immobilization inside microfluidic devices
• Development of quantitative methods to evaluate the surface functionalization
and protein immobilization.
• Functionalization of microchannel surface inside the SMR devices.
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• Stable and reproducible protein immobilization in SMR devices to allow further
kinetic measurements.
• Blocking of non-specific protein binding.
Preparation and characterization of defined seed fibril ensembles for
quantitative measurements
• Establishment of defined ensembles of seed fibrils with a model protein system.
• Evaluation of homogeneity of seed fibril size.
• In situ evaluation of surface density of immobilized seed fibrils inside SMR
devices.
Kinetic measurement and modeling of amyloid elongation using SMR
• Kinetic monitoring of the elongation process of the model protein.
• Interpretation of mechanism and thermodynamics of the elongation process
based on data analysis of kinetic measurements.
• Evaluation of influence of environmental factors (temperature, concentration,
shear stress, salt concentration etc.) on amyloid elongation kinetics.
• Exploration of potential inhibition or degradation candidates for amyloid
elongation based on kinetic measurements.
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Chapter 2
Theory
In the first part of this chapter (Section 2.1.1), the concept of the SMR devices
is presented to introduce the principle, detection modes and characteristics of the
microfluidic transducer. Thereafter, representative surface modification techniques
are reviewed in the Section 2.2 for protein immobilization and surface passivation
inside silicon/glass-based microfluidic devices.
2.1 Microfluidic Devices
Microfluidics is a field of miniaturized systems that make use of channels with
micrometer dimensions to manipulate small amounts (less than several microliters)
of fluids [254,266]. Over the last decade, large varieties of analytical and diagnostic
microfluidic devices have been constantly developed in life science laboratories as
they provide many advantages in terms of low sample consumption, liquid handling
precision and throughput [16,22,50,64,71,262]. An important benefit of using such
devices is that fluid manipulation with small volume (a few picoliters to microliters)
can lead to measurements with fundamentally higher precision [242].
A variety of methods exist to fabricate microfluidic devices. The choice
of the method is determined by factors such as cost, speed, feature size and
material [77,270]. In recent years, polymer-based microfluidic devices fabricated by
soft lithography have widely emerged due to their low cost, rapid and prototype-
friendly fabrication, ease of use and disposability. Polydimethylsiloxane (PDMS)
and poly(methyl methacrylate) (PMMA) are currently the two most widely used
polymers. However, traditional silicon- or glass-based microfluidic devices, which
originated and developed from the semiconductor industry, benefit from mature
high-resolution microfabrication techniques and will continue to be utilized in
23
24 CHAPTER 2. THEORY
many applications. Moreover, glass and silicon are well-known as chemically inert
materials. The initial prototypes of the SMR devices were packaged using PDMS
microfluidics, but the shortcomings of air permeability, compliant characteristics
and limited chemical resistance make robust vacuum packaging of the SMR devices
challenging for optimal performance [35]. Silicon-based microfluidic devices are
therefore more applicable for this purpose. Furthermore, besides the capability for
batch-fabrication, these silicon-based devices are chemically inert and have been
demonstrated to have a shelf life of several years.
2.1.1 Suspended Microchannel Resonators (SMR)
The SMR devices are mass-sensitive microelectromechanical systems (MEMS) and
were first developed to weigh single nanoparticles, single cells and adsorbed layers
of biomolecules in fluid [34, 93, 153]. With a variety of geometries as shown in
Figure 2.1 (b and c) [33, 263], the SMR devices have been integrated with different
techniques such as fluorescence microscopy [236], a pre-concentration element [62]
and surface charge measurement [61]. The method has been implemented for many
applications. To date, the capabilities of these devices for biological and physical
detection have been used to study cell growth [29, 94, 236, 263], cell density [99],
cancer biomarkers [255], dispersion or agglutination of microspheres [49,61,93,203],
and characteristics of binary mixture systems [151, 152]. In the current study, the
SMR devices are employed in combination with surface immobilization techniques
to explore the kinetics, mechanisms and thermodynamics of amyloid growth.
Principles of SMR
An SMR device comprises a vacuum-packaged free-standing resonator, which
encloses a 3 µm high and 8 µm wide microfluidic channel to allow fluid flow, as
shown in Figure 2.1(a). The resonator is driven into mechanical resonance using a
positive feedback loop (Figure 1.9 in Section 1.2). An optical lever detection system
is applied to measure the displacement signal of a reflected laser beam from the
tip of the resonator. In the oscillation circuit, the same signal is amplified, phase
shifted into a positive feedback and connected back to the biased drive electrode.
The resonance frequency shifts when the total mass of the SMR resonator
changes, and this shift is recorded with high accuracy by measuring the difference
between the SMR signal and a manually adjusted reference signal. When damping
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Figure 2.1: Schematics of SMR devices. (a) Working principle of SMR detection. Topview
of (b) cantilever-shaped and (c) torsional resonators.








With the embedded microchannel inside resonator, fluid can fill the device and
contributes to the total effective mass m∗ in addition to the resonator itself. A mass
change ∆m in the fluid or at the solid-liquid-interface results in a new resonance








where α is a geometry-related parameter. The value of α depends on the geometric
localization of the added mass ∆m, α ≈ 1 when a particle in transit is located at
the tip of a cantilever-shaped microchannel, and α ≈ 0.24 when the mass inside
the resonator channel increases uniformly [33]. When molecules are adsorbed to the
microchannel walls, the total mass is composed of the fixed mass of the resonator,
the fluid inside the channel and the adsorbed molecules at the solid-liquid-interface.
Here, the mass of the molecules refers to the buoyant mass mbuoyant, which depends
on the density ρmolecule:
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where ρH2O and mdry are the density of water and the molecule mass in air. As
the density of proteins (monomers and fibrils) is greater than that of water, the
frequency decreases with the accumulation of molecules at the solid-liquid-interface.
Detection modes
Depending on various applications of the SMR devices, two types of detection modes
can be used, as listed below:
Flow-through mode as shown in Figure 2.2 (a). Applying this mode, the
devices can be used to measure the mass of particles that are suspended in the
fluid. When particles flow through the resonator, peak signals can be obtained
with peak heights directly proportional to the mass of the particles. Also, the
resultant frequency shift depends on the mass and position of the particles [34].
Surface-based SMR measurements as shown in Figure 2.2 (b). Channel
surfaces are modified and functionalized to enable molecule adsorption at
the solid-liquid interface. As the ratio of surface area to volume of the SMR
device is large (104 cm−1), a large quantity of molecules can be adsorbed
to the inner walls of the channels. The total mass change of the adsorbed
molecules can thus be measured as a result of frequency shift.
Figure 2.2: Two detection modes of SMR measurements: (a) flow-through mode and (b)
surface-based SMR measurements [34,36].
In this thesis, surface-based SMR measurements are performed to measure the
precise kinetics of the amyloid elongation process. The reliability and stability of
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the detection system will be presented in Section 5.2.
Sensitivity
In surface-based SMR measurements, the total mass change due to a large number
of adsorbed molecules is detected. This approach is advantageous due to the
fact that the mass change can be monitored over an extended time interval until
the signal is significantly above the noise floor. Furthermore, by applying proper
methods to immobilize molecules and passivate the surfaces, the total mass increase
of bound molecules at the solid-liquid interface is measured and false response
arising from nonspecific molecule adsorption can be efficiently reduced [7]. As
such, the sensitivity requirement for the surface-based SMR measurements is less
stringent compared to the flow-through mode, by which the mass of single molecules
would need to be resolved [33].
The mass sensitivity (mass per unit area) of the surface-based SMR measure-
ments is relevant for the kinetic measurements. With constant channel cross-section,
the sensitivity is independent of the exact geometry and vibrational mode of the
channel [33, 36]. Therefore, the mass sensitivity can be estimated by referring to a
double clamped beam with geometric parameters illustrated in Figure 2.3.
Figure 2.3: A double clamped beam to illustrate the mass sensitivity of an SMR device,
taken from reference [33] and [36].
To obtain the sensitivity in surface-binding assays, the resonance frequency ω0
(ω0 = 2πf0) can also be expressed by Equation 2.4 based on the Rayleigh-Ritz
principle,








where U is the potential energy of the displacement field u(z) and mA(z) is the mass
per unit length, expressed as:
mA(z) =
∫
ρ(x, y, z)dxdy (2.5)
Uniform molecule adsorption on the channel walls is assumed to only change the
maximum kinetic energy by added mass but not influence the maximum potential
energy of the resonator. A small mass increase ∆mA, giving rise to a frequency















Equation 2.6 can be further rewritten into equation 2.7 with defined mass per
unit length of the solid-liquid boundary, mA
s












s = 2(H +W ) (2.8)
where H and W are the height and width of the channel.
Equation 2.7 shows the relevance of the parameter of mA
s
for the mass sensitivity.
A decrease in mA
s
will result in enhanced sensitivity to surface adsorbed mass.
In Equation 2.6, the ratio ∆ω
ω0
only depends on the ratio of ∆mA
mA
. The mass
sensitivity can thus be optimized by reducing the resonator mass and by maximizing
molecules adsorbed to the channel surface. In the surface-based measurements, the
frequency resolution of the high quality resonator employed here is approximately
0.01 ppm in a 1 Hz bandwidth. With the known SMR channel dimensions (height
H=3 µm and width W=8 µm), the wall thickness (top and bottom: d=2 µm;
outside: dout=6 µm; between the channels: din=2 µm) and the silicon density
(ρSi=2.336 g/cm3), the minimal detectable surface density σ of molecules adsorbed
















The sensitivity of the SMR can also be measured by calibrating the device using
fluids of different density. Density sensitivity, Sρ, can be obtained by linear regression
using Equation 2.10, which is valid for small density changes ∆ρ:
∆ω
ω0
= −Sρ ·∆ρ (2.10)
The frequency shift per adsorbed mass, SSurface, can then be estimated using
Equation 2.11,






The mass resolution can thus be determined as the product of the frequency
resolution and the reciprocal of SSurface. The mass resolution of the surface-based
SMR measurements has been reported to be 0.01 ng/cm2 [34] and can be further
optimized by reducing the resonator mass and increasing the adsorbed molecule den-
sity. Compared to other mass-sensing methods such as QCM and SPR, the mass
resolution of the SMR devices has been improved by at least five times. Further
shrinking of the SMR channel size to sub-micrometer dimension may yield even
higher sensitivity.
Other characteristics of SMRs
Characteristics of the SMR devices, such as quality factor and drift of the detec-
tion, are important parameters which influence the reliability of surface-based mea-
surements. In the current thesis, long-term stability and a high quality factor are
important for kinetic measurements of amyloid fibril growth. As presented in pre-
vious studies, relevant characteristics have also been assessed [33,34,37]:
Quality factor (Q-factor). High Q-factors (ca. 15,000) can be achieved [33, 34,
263] with dry resonator channels of the SMR devices. Compared to conven-
tional biosensors using micromechanical resonators [16,26,81,83,204,278] that
are immersed in the fluid, both sensitivity and Q-factor of fluid-filled SMRs are
significantly elevated by diminishing high damping and friction drag caused by
the viscosity of fluids. Non-monotonic energy dissipation has been experimen-
tally observed and modeled in terms of viscosity and compressibility of the
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fluid. For specific geometries, no difference in quality factor can be observed
between an air-filled and a water-filled resonator [36].
Drift of the detection. Temperature fluctuations change the resonance
frequency, since temperature can affect the stiffness and stress of the
resonator and the density of the fluid. It has been found that the resonance
frequency decreases as temperature increases [33]. Therefore, it is important
to stabilize the temperature during the measurements for more accurate
detection [152].
2.2 Protein Immobilization Techniques inside Mi-
crofluidic Devices
In microfluidic channels, the large surface-area-to-volume ratio (104 cm−1) makes
surface-based detection with a large number of immobilized molecules on the
surface a powerful biosensing technique. In these measurements, high quality of
the protein immobilization is a prerequisite for good detection performance and
high accuracy [10, 13, 47, 84, 125, 141, 154, 160, 186, 208, 216, 227]. Key performance
parameters to evaluate the immobilization include surface coverage/density, long-
term stability and reproducibility. Immobilization methods vary largely with the
targeted surfaces, protein characteristics and aimed application.
Surface functionalization, the generation of reactive functional groups on
the surface, is the critical step prior to the protein immobilization step.
Functionalization leading to planar or three-dimensional (3D) protein immo-
bilization can be conducted using different linkers, as shown in Figure 2.4. In
contrast to planar immobilization with short-length crosslinkers (e.g. aminosilanes,
epoxysilanes), polymeric hydrogels such as polyacrylamide gel (PA), dendrimers,
polyethylene glycol gel (PEG) and dextran are used to form 3D linker matrices
with a large number of protein binding sites [114, 133, 222, 253]. This provides a
high protein capture capacity which can improve detection sensitivity compared
to planar immobilization. Furthermore, hydrogels with long spacers can provide a
hydrophilic environment which favors protein stability and allows proteins to retain
their activity.
For many specialized biosensing methods such as SPR and QCM, proteins are
immobilized on metal films deposited on glass or quartz surfaces. The corresponding
immobilization techniques have been well developed and documented so far [108].
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Figure 2.4: Schematic drawing of protein immobilization with different binding geome-
tries such as planar structure and 3D structures.
For example, thiol-based chemistry is often applied for protein immobilization on
noble metal surfaces including gold, silver and platinum [133]. As the SMR and
other microfluidic devices used in this thesis do not make use of such surfaces, the
related protein immobilization techniques will not be discussed here. In contrast,
possible immobilization techniques will be reviewed in detail for silicon, glass and
PDMS-polymer surfaces. All these surfaces share a similar surface chemistry,
therefore the applied immobilization techniques are similar. Large varieties of
immobilization methods are categorized into covalent coupling, physisorption,
bioaffinity interaction and their combination as illustrated in Figure 2.5 [133].
Figure 2.5: Schematic drawing of protein immobilization concepts via covalent coupling,
phsisorption (e.g. electrostatic interaction) or bioaffinity interaction.
2.2.1 Covalent Coupling
Covalent coupling is frequently used to immobilize proteins with accessible
functional groups of exposed amino acids. Covalent bonds are irreversible and in
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most cases stronger than other intermolecular interactions and bioaffinity interac-
tions. Depending on the functional groups that are used to modify the surface or to
link the targeted proteins, multiple surface functionalization steps are required prior
to the protein immobilization step. Here, the conjugation chemistries which can
be employed in silicon/glass-based microfluidic devices are reviewed [222]. Starting
from the functionalization of the native solid surface, possible immobilization
pathways are summarized in Figure 2.6 and Table 2.1.
Typically, microchannel surfaces with naturally or artificially grown silicon
dioxide are initially functionalized using silane chemistry [91]. The applied organo-
silanes usually contain a functional group (e.g. amine, aldehyde, epoxy groups) at
one end and a surface reactive group (e.g. alkoxy and chloro groups) at the other.
In this study, aminosilanes (APTMS and APDMMS) with surface-reactive alkoxy
groups were in use. Various protocols for aminosilane deposition have been reported
on open-surface systems [108]:
Liquid-phase deposition. The liquid-phase deposition of amino alkoxysilanes has
been accomplished in either organic solvents (e.g. toluene, acetone, hexane
etc.) or aqueous solvents (e.g. water) [91, 108]. The suggested mechanism is
presented in Figure 2.7. In both solvents, the alkoxy groups of the silanes,
e.g. the methoxy groups of APTMS and APDMMS, initially undergo a fast
hydrolysis to form silanols, followed by a condensation reaction with the surface
hydroxyl groups as presented in Figure 2.7 [60, 91, 173]. The methods are
convenient to use due to their simplicity and low setup cost. However, the
quality of the formed layers are highly sensitive to the presence of water in the
system. Polymerization of hydrolysed silane molecules can easily occur. In
microfluidic systems, the liquid phase deposition is further limited by solvent
compatibility with device materials.
Vapor-phase deposition. The vapor deposition method can be applied to surfaces
by volatilization of organosilanes under heat or vacuum within a closed system
[91, 108, 209, 224]. The reaction mechanism is assumed to be similar to the
aforementioned mechanism [69]. The approach has the advantage over liquid-
phase deposition that only a small amount of organosilane is used and that
layers with higher homogeneity and quality can be routinely formed. The
vapor-phase deposition of organosilanes is attractive for closed microfluidic
systems, but its practical potential has not yet been fully explored. In this
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Table 2.1: Surface functionalization of silicon/glass-based microfluidic devices for protein
immobilization.
Group Group Step Reagent
(on surface) (to functionalize)
Hydroxyl Amine I APTMS; APTES; APDMMS [40,
69,108]
Carboxylate II Carboxyethylsilanetriol; TMS-
EDTA [108]
Epoxide III GOPTMS; GOPTES; EPPTMS
[72,108,182,251,269]
Isocyanate IV ICPTES [108,133]
Thiolate V MDS; MTS [19,108]
Amine Disulfide VI 2-Iminothiolane; SPDP [85, 108,
190]
Aldehyde VII Glutaraldehyde; Dextran/NaIO4
[108,122,133,269,274]
Maleimide VIII S-SMCC; S-SMPB; BMH; EMCS
[85,133,222,269]
NHS-ester IX EDC/NHS [108,133,269]
Carboxylate X Glutaric anhydride; Citraconic an-
hydride; CM-dextran cis-Aconitic
anhydride [85,108,246]
Carboxyl NHS-ester XI NHS [108,121,269]
Epoxide Carboxylate XII CM-dextran [72]
Sulfhydryl Disulfide XIII SPDP; TNB [108]
thesis, surface functionalization with aminosilanes using vapor-phase deposi-
tion is introduced and characterized in closed microfluidic devices.
Although many of the mentioned methods have been well established for open
surface systems, they can still be generally improved. Moreover, the implementation
of those methods for closed microfluidic devices is challenging due to the high risk
of clogging and the susceptibility to cross-contamination of reagents. As such,
protocols for reliable protein immobilization need to be tested and optimized for
microfluidic systems, especially for the SMR devices.
Once the first layer of functional groups is introduced to the surfaces (Figure
2.6 and Table 2.1, (I)–(V)), protein immobilization is readily possible (Figure 2.6,
(XVII) and (XIX)–(XXI)). Alternatively, subsequent functionalization can also
34 CHAPTER 2. THEORY
modify the initially introduced functional groups and change the reactive groups
with spacer arms or crosslinkers (Figure 2.6 and Table 2.1, (VI)–(XIII)). Proteins
are then immobilized on the second functional layers of the surfaces (Figure 2.6,
(XIV)–(XVI) and (XVIII)).
Using different functional groups, covalent coupling of proteins can be carried
out by designing a site-specific reaction between functional groups of the proteins
and the surfaces. The site-specific immobilization could allow reproducible im-
mobilization and the binding sites can be designed in ways that do not affect the
stability and functionality of the proteins. Depending on the commonly available
protein functional groups located at N-, C-terminus or in the exposed side chains,
the most commonly applied protein coupling techniques are classified into amine,
carboxyl, thiol and hydroxyl couplings (Figure 2.6 and Table 2.1).
Amine coupling. The nucleophillic amine groups can react with surface epoxide
groups, functionalized with e.g. GOPTMS, in a ring-opening process (X-
IX) [108, 133]. Secondary amines are created under high pH conditions usu-
ally in the range of pH > 9. Alternatively, the interaction between protein
amine groups and surface aldehyde groups leads to the formation of a labile
Schiff’s base that can be stabilized by reduction using sodium borohydride or
sodium cyanoborohydride (XV). In this study, APTMS was used to introduce
amino groups on the native glass/silicon surfaces (I) and glutaraldehyde was
subsequently applied to generate surface aldehyde groups (VII) for amyloid
seed fibril coupling. The amine groups of proteins can also react with func-
tional isocyanate groups on the surfaces at alkaline pH values (XX). One draw-
back of the method is that unstable isocyanate compounds can be decomposed
rapidly by moisture. Another common immobilization reaction is the protein
amine coupling to NHS-ester activated surfaces (XVIII). The NHS-esters on
the amine-modified surfaces can either be generated by applying bifunctional
NHS-esters (IX) (e.g. DSS and S-SMCC) or by partially activating the car-
boxyl groups of the coupling agents (e.g. CM-dextran in this study) (X) with
EDC/NHS , followed by another EDC/NHS-activation-step to enrich the sur-
face carboxyl groups (XI). The reaction creates stable amide linkage rapidly
under physiological pH conditions, but hydrolysis of the NHS-esters should be
taken into account in practice. Amine coupling can be applied to link nearly
all protein molecules with amine groups at their N-terminus. Some proteins
also contain lysine residues in the side chains.
Carboxyl coupling. Functional carboxyl groups exist at the C-terminus of a pro-
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tein and in aspartic acid and glutamic acid residues which can be present at
protein surfaces. The protein coupling to the amine-modified surfaces requires
an additional step to activate the carboxyl groups due to their low nucleophi-
licity. CDI can be used to activate the carboxyl groups of proteins for further
coupling (XVII). The optimal conditions include alkaline solutions in the range
of pH 7–9. Alternatively, EDC/NHS can also efficiently activate the carboxyl
groups of proteins. However, care must be taken when using these methods,
as proteins also contain amine groups in themselves and a self cross-linking
could occur in the solutions.
Thiol coupling. Reactive groups that are able to react with protein sulfhydryl
groups are the second most common groups. As illustrated in Figure 2.6,
direct formation of disulfide bonds takes place between sulfhydryl-containing
proteins and surfaces (XXI). Alternatively, thiol-disulfide exchange reactions
are used to couple sulfhydryl-containing proteins to surface disulfide groups (X-
IV). An important feature of this process is that the bonds are reversible using
disulfide reducing agents such as DTT or TCEP, allowing regeneration of the
surface functional groups. Alternatively, maleimides are favorable functional
groups that are contained in many heterobifunctional crosslinking agents. The
alkylation reaction of protein sulfhydryl groups with the double bond of surface
maleimide groups undergoes efficiently at pH 6.5–7.5 (XVI). However, hydroly-
sis of the maleimide groups in form of a ring-opening reaction may occur before
and even after the sulfhydryl coupling. Similar to protein amine coupling, re-
active sulfhydryl can react with surface epoxy groups (XIX). The required pH
condition is closer to the physiological range of 7.5–8.5 [108]. The reaction
of sulfhydryl groups with NHS-esters does not yield stable conjugates and is
therefore not applicable.
Hydroxyl coupling. Similar to the coupling of amine and sulfhydryl groups to
epoxy-modified surfaces, hydroxyl groups of serine and threonine residues con-
tained in proteins can react with the surface epoxy groups in a ring-opening
process. The reaction with hydroxyls (XIX) requires high alkaline conditions
(pH 11–12). Hydroxyl groups can also bind to isocyanate groups on the sub-
strate surfaces (XX).
2.2.2 Physisorption
Physisorption (or physical adsorption) is frequently employed in protein immobi-
lization [132, 221]. By physisorption, proteins adsorb to silicon dioxide surfaces via
intermolecular forces such as electrostatic, hydrophobic, van der Waals or hydrogen
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bonding interactions. Compared to covalent coupling methods that usually require
multistep operations and long incubation periods, physisorption can normally
be performed quickly and conveniently, which makes it a preferred method for
protein immobilization in early, proof-of-principle experiments. However, several
drawbacks limit the application of the method: (1) physically adsorbed proteins
are not as stable as proteins immobilized by covalent or bioaffinity binding; (2) the
immobilized protein layer is randomly oriented; (3) it is challenging to generate
reproducible physisorption since the intermolecular forces highly depend on envi-
ronmental conditions such as pH, ionic strength and temperature; (4) the density
of adsorbed molecules is generally difficult to evaluate; and (5) the prevention of
non-specific binding is difficult.
Electrostatic Functionalization
In protein chemistry, functional groups of protonated amine (—NH+3 ) and quater-
nary ammonium cations (—NR+3 ) contribute to the positive charge of proteins and
functional groups of carboxylic acid (—COO−) and sulfide (—S−) contribute to the
negative charge. The overall net charge is related to the electrostatic interaction
between the protein and a surface. The proteins used in this thesis (αS, insulin)
to study amyloid formation are negatively charged in physiological solutions, with
pI values lower than pH = 7. In contrast, silicon dioxide surfaces are negatively
charged with deprotonated hydroxyl groups when the pH value of the solution is
greater than pH 4. Poly-L-lysine (PLL) is frequently used to generate positive
surface charge and to link the negatively charged proteins. In this study, PLL has
been employed to immobilize αS seed fibrils on the walls of the SMR channels.
In case that positively charged proteins are desired to be immobilized, generation
of an additional surface layer with negative charge, e.g. by use of polyacrylamide
(PA) gels, is an alternative to direct binding of proteins to the surface. Compared
to the direct interaction on the SiO2 surface, the interaction can be enhanced by
generating more negative charge. The electrostatic interaction is generally stronger
than other physisorption interactions.
Functionalization Based on Intermolecular Forces
The hydrophobic interaction, hydrogen bonding and Van-der-Waals interaction
are common adhesion forces that can be used to functionalize solid surfaces by
physisorption [133]. Protein immobilization using hydrophobic interactions has
been frequently applied on many microfluidic devices made of PDMS, PMMA
2.2. PROTEIN IMMOBILIZATION 37
and other polymeric hydrophobic materials. The simplicity makes it a preferred
immobilization method in early, proof-of-concept experiments.
2.2.3 Bioaffinity Interaction
The bioaffinity interactions have advantages of specificity and binding orienta-
tion. In addition, the bioaffinity interactions can be significantly stronger than
electrostatic interaction and can sometimes be regenerated with chemical treatment,
pH change or heat treatment [133]. Combined with either physisorption or covalent
coupling techniques, bioaffinity reagents are mostly used as intermediate binding
molecules between the surface and proteins [108,156].
One of the most widely employed bioaffinity interaction candidates is avidin-
biotin. Avidin or its derivatives (e.g. streptavidin, neutravidin or nitrividin) can
be physisorbed or covalently bound to the surface. Regardless of pH, tempera-
ture or denaturing agents, biotinylated proteins can bind to the avidin rapidly.
The limitation of the method is that additional biotinylation is required for proteins.
Beside the avidin-biotin binding, several other protein immobilization methods
using affinity interaction exist [222]: (1) a single-strand DNA (ssDNA) can be
attached to the protein as a tag and can further bind to the pre-immobilized
complementary DNA on the surfaces via specific hybridization; (2) protein A and
protein G, which are extracted from bacteria, can be used to bind specifically
to antibodies (IgG); (3) immobilized antibodies are able to capture the targeted
antigen epitope and (4) polyhistidine tags of proteins interact specifically with
metal ions (Ni2+, Cu2+, Zn2+ etc.).
2.2.4 Combination of Immobilization Techniques
Covalent coupling, physisorption and bioaffinity interactions can be combined to
address the limitations of each method and to achieve a better control of protein
immobilization. The most common combinations include physisorption–covalent
coupling [273], covalent–bioaffinity immobilization [75, 149, 244], physisorption-
bioaffinity immobilization [34, 68, 161, 226] and covalent–physisorption–bioaffinity
immobilization [67, 234, 275]. In addition to all the common chemical agents that
are used to perform the surface functionalization and protein immobilization,
natural adhesives have recently been reported to be able to functionalize sur-
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faces [150,162,185,257]. Polydopamine that is secreted by mussels contains plentiful
catechol and amine functional groups and forms strong covalent and hydrophobic
interactions with virtually all types of inorganic and organic surfaces, including
silicon oxide, polymers and even noble metals. Polydopamine-modified surfaces
serve as a multifunctional platform for further protein coupling and interaction.
In microfluidic systems, the evaluation criteria for an optimal combination are
sufficient density, retained biological function of the immobilized molecules, low
non-specific binding and stability in the presence of continuous flow conditions.
In this study, electrostatic and covalent immobilization techniques have also been
combined to immobilize amyloid seed fibrils. PLL-grafted-carboxymethyl(CM)-
dextran binds to the SiO2-surfaces via the interaction of positively charged lysine
residues with the negatively charged surfaces. Furthermore, the carboxyl groups can
be activated using EDC/NHS solutions and the seed fibrils can thus be covalently
bound to the dextran matrix on the surface. These immobilization techniques have
been assessed with regards to stability and non-specific adsorption, and the results
are presented in Section 5.1.2.
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Figure 2.6: Covalent immobilization of proteins to silicon and glass surfaces with different
functional groups. The reagents used for steps (I)–(XIII) are listed in Table 2.1. The site-
specific protein couplings with surface functional groups correspond respectively to steps
(XIV)–(XXI).
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Figure 2.7: Mechanisms of covalent coupling of alkoxysilanes with surface hydroxyl
groups. The RO- group here stands for any alkoxy group (in this study: the methoxy
groups of APTMS and APDMMS).
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2.3 Surface Passivation
Surface passivation is necessary to block the remaining functional groups after
protein immobilization and to prevent non-specific molecule adsorption. In surface-
based SMR measurements or other biosensor techniques, low non-specific protein
adsorption contributes to low background signal. In this thesis, sufficient surface
passivation of protein monomer molecules ensures the reliability and precision of
amyloid kinetic measurements. As a subsequent step after surface functionalization
and protein immobilization, the passivation can be carried out by physisorption or
covalent binding.
Physisorption
Albumin-based agents, e.g. BSA, can bind to the glass/silicon surfaces as a result of
hydrophobic interaction, preventing further adsorption of proteins to the surfaces.
Electrostatically, hydrophillic dextran or PLL-grafted PEG agents are widely
used to prevent non-specific binding of proteins. PLL-grafted-CM-dextran has
been deposited on the SMR channel surfaces to suppress non-specific adsorption
of αS fibrils. Furthermore, the direct use of zwitterionic polymers, such as
poly(carboxybetaine), has been reported to efficiently suppress the non-specific
protein adsorption on hydrophobic surfaces (e.g. PDMS) while providing specific
functional groups for protein immobilization [126]. More recently, lipid bilayer
membranes have been developed to modify the inner walls of microfluidic channels
since hydrophobic interaction and Van-der-Waals force enables lipid deposition
on the surfaces. The lipid bilayers are able to provide better passivation than
albumin-based agents [117,207].
Covalent passivation
To avoid proteins interfering with the subsequent reactions or application, passiva-
tion of the functional groups in excess after the specific protein immobilization is of
great importance. The passivation molecule is usually a small compound containing
a functional group able to couple with the surface functional group at one end and
a group at the other end that does not interact with proteins. The passivation com-
pounds are selected depending on the surface functional groups, and the reactions
are similar to those of protein coupling with surface functional groups described in
the covalent coupling section (2.2.1).
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Passivation of surface amine groups. Several acylation reagents, such as sulfo-
NHS acetate and acetic anhydride, have been reported to effectively passivate
the primary amine groups [108].
Passivation of surface sulfhydryl groups. Partis et al. used maleimide
reactions to form thioether linkages and specifically block the reactive
sulfhydryl groups in pH 6.5–7.5 [201]. N-Ethyl maleimide is a permanent
blocking agent. In contrast, reversible passivation can be performed using
Ellman’s Reagent or other disulfide agents to form disulfide bonds, which can
be cleaved by addition of reducing agents such as DTT.
Passivation of surface aldehyde groups. Amine-containing molecules, such as
ethanolamine, Tris and hydrazides, can be applied to block the reactive alde-
hyde groups on the surface by forming secondary amine linkages in reductive
amination procedures.
Passivation of surface carboxylate groups. Similar to passivation of surface
aldehyde groups, amine-containing molecules can also be applied to passivate
the carboxylate groups. However, additional EDC molecules are required in
the precedure to activate the carboxylate groups for the coupling.
Chapter 3
Materials and Methods
3.1 Chemicals and Materials
All chemicals that were used for buffer preparation, cleaning, surface modification,
surface characterization, and kinetic measurements (elongation rate determination,
dissociation monitoring, inhibitor screening) are listed in Table 3.1.
3.2 Facility
Important facilities used in the current thesis for the sample and manifold prepara-
tion, fluorescence detection, fluid delivery and detection systems of the transparent
microchannels and the SMR devices are listed in Table 3.2.
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Table 3.1: Chemicals for the experiments.
Application Chemicals Company
Cleaning H2SO4(98%), ethanol, NaOH (1 M) Merck, Germany
H2O2 Fisher Scientific, Germany
Buffer HEPES, PBS(10x conc.) Carl Roth, Germany
Glycine
Silanization APTMS, APDMMS Sigma-Aldrich, Germany
AF555-NHS Invitrogen, Germany
NHS-biotin Pierce Biotechnology, USA
Immobilization PLL, Human insulin, PLGA, NaCN Sigma-Aldrich, Germany
Glutaraldehyde, NaCNBH3, NaN3, NaCl Carl Roth, Germany
EZ-link Sulfo-NHS-LC-biotin Thermo Scientific, Germany
rAcGFP1 Clontech, Germany
PLL-grafted-CM-dextran SuSoS, Switzerland
CM-dextran (70 kDa) TdB-Consultancy, Sweden
αS MPIBPC (Prof. Zweckstetter)
Germany
NDA, AF555-NHS-ester Invitrogen, Germany
Kinetics Ectoine, Trehalose Carl Roth, Germany
CaCl2, MgCl2 ZnCl2 Carl Roth, Germany
Methylene blue Roth, Germany
PcTS MPIBPC (Prof. Zweckstetter)
Germany
Microbead NIST (1.5 µm) Polysciences, USA
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Table 3.2: Important facilities used in the experiment.
Equipment Company
TKA MicroPure Ultra Pure Water System Thermo Fisher Scientific, Ger-
many
NanoDrop 3300 florospectrometer
NanoDrop 2000c UV-VIS spectrometer
FEMTO Surface Plasma Cleaner Diener Electronic, Germany
Inverted Axio Observer D1m Microscope Zeiss, Germany
Filter set 44 and 75HE
Objective 5x, 10x, 20x, etc.
ULTRASONIC cleaner VWR, Germany
Centrifuge 5430R Eppendorf, Germany
Universal oven Mommert, Germany
VERSALASER Universal Laser System, USA
LabRoutine PH-meter METTLER TOLEDO, Switzer-
land
ABT 1205 DM balance KERN, Germany
Incubator AQUAR© LYTIC
Pressure regulator and manometer RV Regler &Verfahrenstechnik,
Germany
Electrical pressure regulators and valves SMC Pneumatik, Germany
Autosampler Agilent, USA
300 MHz Synthesized function generator Stanford Research Systems, USA
Tektronix TDS 2004B Oszilloscope Farnell, Germany
TED 200c Temperature controller Thorlabs
Other optical components
Laboratory DC power supply GPS-2303 GWINSTEK, USA
NI-DAQ & Labview National Instrument, USA
CCD Camara Andor Technology, Ireland
Bode analyzer Omicron LAB, USA
SMZ-168 Stereo Zoom Microscope Motic, Germany
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3.3 Sample Preparation
3.3.1 Fabrication of SMR Devices
The applied SMR devices, torsional microresonators with embedded 3 x 8 µm
microchannels, were fabricated on six inch silicon wafers at Innovative Micro
Tech-nology (Santa Barbara, CA) and obtained from the laboratory of Prof. Scott
Manalis (MIT, Cambridge MA) [34]. The fabrication process was described in
Reference [34]. The fluid interconnects to the SMR chip were made using a Teflon
manifold.
3.3.2 Fabrication of Transparent Microchannels
Transparent microfluidic devices with microchannels that are similar in design to
SMR microchannels were fabricated by H. Feindt using conventional microfab-
rication techniques at the Center of Advanced European Studies and Research
(caesar, Bonn, Germany). Devices with 75 x 66 µm microchannels were fabricated
on four inch silicon wafers using lithographic patterning, deep reactive-ion etching
(DRIE) on both sides and anodic bonding to a plain borofloat wafer. Devices with
0.7 x 2 µm nanochannels were fabricated similarly by first patterning the shallow
channels followed by patterning the deep bypass channels. The fabrication and
packaging process of such nanochannel devices is depicted in Figure 3.1.
3.3.3 Preparation of Insulin Fibrils
Preparation of monomer solutions
Inuslin monomers were freshly dissolved in 1 mL of either HEPES (10 mM) or
glycine buffer (50 mM) at pH 2 with concentrations ranging from 1–6 mg/mL for
further fibril formation. For concentration-dependent elongation measurements, the
insulin monomers were prepared with concentrations of 0.06, 0.1, 0.2, 0.4, 0.6, 0.8, 1,
2, 4, and 6 mg/mL. All the concentrations were determined by UV-VIS spectroscopy
at 280 nm absorption wavelength. The monomer solutions were centrifuged at
30 000 g for 30 minutes at 4◦C and only the supernatant of the solutions was
carefully removed with pipettes for further use. In the concentration-dependency
measurements, the monomer insulin solutions were kept at 4◦C until they were used
for the real-time measurements.
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Figure 3.1: Fabrication and packaging process of transparent nanochannels
(700 nm x 2 µm ): (a) 4” silicon wafer (300 µm thick, < 100 > orientation); (b) Patterning
nanochannels using photolithography; (c) RIE; (d) Patterning deep bypass channels using
photolithography; (e) DRIE; (f) Resist strip and cleaning with piranha solution; (g) Anodic
bonding with borofloat glass; (h) Patterning inlet and outlet holes using photolithography
on back side; (i) DRIE; (j) Dry resist strip using oxygen plasma.
Preparation of long insulin fibrils
The fresh monomer solutions were incubated at 37◦C in 1.5 mL borosilicate glass
vials with rubber-lined closures. To standardize the measurements, 6 mg/mL mono-
mer solutions were used to start long fibril formation. The solutions were stirred
with micro stirring bars (3 x 7 mm). At two hour intervals, the vials were gently
shaken to distribute fibrils evenly in the vials before withdrawing 3 µL aliquots to
measure the fluorescence by binding with ThT. The fibril formation was complete
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when the fluorescence intensity did not increase.
The long fibrils were also prepared by seeding short fibril fragments with the
same starting concentrations in monomer solutions. The solutions were incubated
similarly and the fibril formation ended within 2–4 hours. The solutions were stored
at room temperature.
Preparation of short insulin fibrils
Short insulin fibrils were an important basis as seeds for the quantitative kinetic
measurements. To obtain short insulin fibrils of uniform size, the solutions
with long insulin fibrils (starting concentration of 6 mg/mL) in HEPES buffer
(10 mM, pH 2.0) were diluted by a factor of six and ultrasonicated for 2.5 h
with 15 minutes intervals at 4◦C. The ultrasonicated samples were quickly trans-
ferred into 0.2 µm Millipore-filter vials and filtered at 12 000 g at room temperature.
3.3.4 Preparation of αS Fibrils
The samples of wt-αS fibrils and monomers were obtained from the Department
of NMR-based Structural Biology of the Max Planck Institute of Biophysical
Chemistry, Göttingen, Germany. The stock αS fibril solutions (starting concen-
tration of 20 µM, ca. 0.3 mg/mL) were kept at room temperature. Prior to use,
the sample solutions were treated with ultrasonication for 10 minutes at room
temperature.
3.3.5 Surface Functionalization with Silane Coupling Agents
Vapor phase deposition of aminosilanes
Microfluidic channels were silanized using 3-aminopropyl trimethoxysilane (APTMS)
by vapor phase deposition as shown in Figure 3.2. Firstly, the microchannel devices
were treated with atmospheric plasma at a pressure of 0.4–0.6 mbar for 10 minutes
to clean the external surfaces. APTMS (3 µl) was then transferred into 10 mL vials
in an argon filled glove bag to avoid trace amount of water. The capped glass vials
were then incubated at 40–80◦C for 6–16 h. To maintain an unsilanized reference
channel, one channel was protected with KaptonR© tape. All tape was removed
prior to rinsing with ethanol. Afterwards, the devices were removed from the glass
vials and connected to a pressure controlled fluidic manifold. All channels were
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then rinsed thoroughly with ethanol and dried with nitrogen gas.
Figure 3.2: Reaction schematic for covalent attachment of NHS-based molecules to silicon
and glass substrates. (a) Vapor phase deposition of APTMS; (b) Labeling the reactive
amine functional groups with AF-NHS-ester (R1 = Alexa FlourR© 555; R2 = H) and/or
sulfo-NHS-biotin (R1 = LC-biotin; R2 = −SO−3 ).
Vapor phase silanization was also performed on borofloat glass slides
(ca. 9 × 12 mm). The slides were initially cleaned in piranha solution for a
minimum of 30 minutes. The slides were then thoroughly rinsed with pure water,
dried under nitrogen gas, and plasma treated for 10 minutes. To maintain an
area of the slides unsilanized, one half on both sides of the slide was covered with
KaptonR© tape.
Liquid phase deposition of aminosilane
To perform the liquid deposition, APTMS was dissolved in toluene at a concentration
of 5% and also in ethanol with a concentration of 2% (v/v).
Using toluene as the solvent, the solution was transferred into the transparent
microchannels using chemically resistant FEP tubing. The surfaces were incubated
with the APTMS toluene solution for 20 h at room temperature and then rinsed
with toluene, isopropanol, and water for at least 10 minutes respectively.
The APTMS in ethanol was introduced to the microchannel surfaces, incubated
for 2 h at room temperature and then rinsed with ethanol and water.
3.3.6 Protein Immobilization and Passivation
3.3.6.1 Covalent Coupling of Insulin Fibrils
Short insulin fibril samples obtained as described in Section 3.3.3 were immobilized as
illustrated in Figure 3.3 following the same procedure in transparent microchannels
and SMR devices. The flow direction inside the small microchannels was controlled
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by changing the pressure differences at inlet and outlet of both connected bypass
channels. The immobilization process is detailed as follows:
(I) Functionalization with amine groups. The in-channel functionalization
was done by vapor phase deposition of APTMS as described in Section 3.3.5.
The microchannels were then rinsed with ethanol and subsequently with wa-
ter. In addition, the microfluidic devices were heated and maintained at 37◦C
for further coupling and immobilization.
(II) Functionalization with aldehyde groups. To introduce reactive aldehyde
groups, glutaraldehyde solution (50% in water) was diluted by a factor of five
times and centrifuged at 30 000 g for 15 minutes at 4◦C to reduce the content
of large glutaraldehyde aggregates in solution. The supernatant was carefully
removed and introduced into the bypass channels and the small microchannels
for 5 minutes followed by replacing with water. The reducing agent, NaCNBH3,
was dissolved in water at a concentration of 10 mg/mL and introduced into
all the channels for 10 minutes to stabilize the immobilized aldehyde groups
on the surfaces.
(III) Immobilization of insulin seed fibrils. The solutions inside all mi-
crochannels were replaced with HEPES buffer (10 mM, pH 2.0). The solutions
with short fibrils obtained as described in Section 3.3.3 were introduced to one
of both bypass channels and the small microchannel and reacted with the func-
tionalized surfaces for 15 minutes while the other bypass channel was filled with
the HEPES buffer. The insulin seeds were then replaced with HEPES buffer,
and all the channels were changed back to water followed by stabilizing the
proteins on the surface with 10 mg/mL NaCNBH3 solution for 20 minutes.
(IV) Passivation of the reactive surfaces. The flow direction was changed
from the bypass channel without immobilized seed fibrils (the left channel
in Figure 3.3) to the one with immobilized seeds (the right channel). The
glycine buffer (50 mM, pH 2.0) was used to passivate the remaining aldehyde
groups in the left bypass channel and the small microchannel for 10 minutes,
followed by NaCNBH3-reduction for 20 minutes and then filled with water.
(V) Insulin elongation measurements. The channels were all filled with the
buffer solutions and inuslin monomer solutions were then introduced to the
small microchannel from the passivated site.
(VI) Surface cleaning and regeneration. To reuse the same microfluidic de-
vices, pirahna solutions were applied for 10 minutes to clean all the channel
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surfaces followed by rinsing with water. The native surfaces with hydroxyl
groups were thereby regenerated and ready again for surface functionalization
with aminosilanes.
Figure 3.3: The covalent immobilization of seed insulin fibrils for elongation detection
via (I) functionalization with amine groups; (II) functionalization with aldehyde groups;
(III) immobilization with insulin seed fibrils; (IV) passivation of the reactive surfaces; (V)
insulin elongation measurements and (VI) surface cleaning and regeneration.
3.3.6.2 Electrostatic Adsorption of αSynuclein
Poly-L-lysine and PLL-grafted-CM-dextran were used to immobilize αS seed fibrils
in the early elongation experiments. αS fibrils were ultrasonicated for 10 minutes
at room temperature to obtain short seed fibrils in fragments.
Fibril immobilization using PLL
Initially, the microchannels were filled with water. PLL solutions (0.1 mg/mL,
70–150 kDa) were introduced to the microchannel surfaces for 10 minutes and
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replaced with water and subsequently HEPES buffer at pH 6.5. Seed αS fibrils
were injected into one of the two bypass channels and the small microchannel for
15 minutes. After rinsing with buffer solution, monomer solutions with various
concentrations were introduced to start fibril elongation.
Fibril immobilization using PLL-grafted-CM-dextran
αS seed fibrils were also immobilized using PLL-grafted-CM-dextran, which was
dissolved in water at a concentration of 1 mg/mL and mixed with an aqueous
solution of 0.8 M EDC and 0.2 M NHS at the volume ratio of 1:1. The mixture was
injected into the microchannels for 5–10 minutes to generate functional carboxyl
groups on the surface and then replaced by water and HEPES buffer (50 mM,
100 mM NaCl, pH 6.5). The surface functional groups were then further activated
with the aqueous EDC/NHS-solution for one minute, followed by the injection of
αS fibril solutions for 15 minutes.
3.3.7 Microchannel Surface Regeneration
The surfaces of inner walls inside the transparent microchannels and SMR devices
were cleaned and regenerated with piranha solution (2:1 sulfuric acid/hydrogen per-
oxide).
Alternatively, alkaline NaOH solutions (0.1 M) were also used to regenerate the
native surfaces with hydroxyl groups for one hour. This method was applied in
transparent microchannels. In SMR devices, the NaOH-cleaning was inappropriate
since NaOH can thin the silicon walls of the suspended microchannel, enhancing
the risk of leaking into the vacuum cavity surrounding the resonator.
3.4 Biophysical Detection Techniques
3.4.1 Fluorescence Quantification of Amine Groups
3.4.1.1 Fluorescence Labeling
Labeling with fluorescent NHS-esters
Fluorescence labeling of amine modified surfaces was performed using AF555-NHS
alone (5 and 10 µM) or with a mixture of AF555-NHS-ester and sulfo-NHS-biotin as
3.4. BIOPHYSICAL DETECTION TECHNIQUES 53
shown in Figure 3.2. Mixtures were prepared from the solutions of AF555-NHS-ester
(70–350 µM)and sulfo-NHS-biotin (5–5.5 mM) in 10 mM HEPES buffer at pH 8.
The total solution concentration of NHS esters was kept constant at 5 mM for all the
mixtures while varying the stoichiometry of AF555-NHS-ester and sulfo-NHS-biotin.
The resulting AF555-NHS-ester concentration in each solution mixture ranged from
1.25 µM to 40 µM and the corresponding mole fraction was 0.025 % to 0.8 %. All
the solutions were freshly prepared to minimize the hydrolysis of the NHS esters.
The silanized microfluidic channels were then labeled by continuously flowing 150
µL of NHS ester solution through the channel for 60 minutes at room teperature
in a dark room. After labeling, the channels were rinsed with HEPES buffer and
water before drying with nitrogen gas.
Functionalized glass slides were also labeled with the same concentrations
of AF555-NHS-ester and sulfo-NHS-biotin. Slides were sandwiched betwen two
glass coverslips with 30 µL of solution covering each side and incubated at room
temperature for 60 minutes. The slides were then rinsed with water and dried with
nitrogen gas.
Based on the detection over a wide range of labeling concentrations, the standard
mixture solution was set at 2.5 µM AF555-NHS-ester (the mole fraction of 0.025%)
and 5 mM sulfo-NHS-biotin for direct quantification and real-time monitoring.
Labeling with fluorogenic reagents
Non-fluorescent NDA was dissolved in methanol at a concentration of 1 mM. For the
detection of surface amine groups inside microchannels, 200 µL NDA solution was
mixed with 200 µL sodium borate buffer (10 mM, pH 8.0) and 50 µL soldium cyanide
solution (10 mM) prior to injection. The mixture was introduced to the channel
surfaces for 10 minutes to generate fluorescent products (λexcitation = 350 nm,
λemission = 410 − 451 nm) by reaction with amine groups as shown in Figure
3.4. Fluorescence intensities were observed under the fluorescence microscope.
For the detection of amine groups in solutions, 50 µL of samples were added into
the mixture and the aliquot was measured with a Nanodrop 3300 fluorospectormeter.
3.4.1.2 Fluorescence Imaging and Intensity Measurements
All fluorescence experiments were conducted in microfluidic channels under buffer
flow unless otherwise specified. The device was mounted onto the inverted micro-
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Figure 3.4: Schematic of fluorogenic reaction using NDA to label amine groups on the
surfaces of the microchannels or in solution.
scope with the 10x, 0.2 NA objective and fluorescence images were captured with
the CCD camera. AF555 dye was excited at 537 ± 25 nm and the emission was
observed at 610 ± 96 nm. Controlled fluid flow was achieved by pressurizing the
headspace of sealed autosampler vials. Fluorescence images were acquired with an
exposure time of 1 s. Fluorescence intensity of each channel was analyzed with
Image J software. Each experimental condition was performed in triplicate.
Non-specific adsorption of AF555-NHS-ester was controlled by simultaneously
monitoring the fluorescence in reference channels. The intensity from the reference
channel was used as background and substracted from fluorescence measurements
of the other channels in the same image.
Fluorescence intensity measurements were calibrated using known AF555-NHS-
ester concentrations in a microfluidic channel of defined depth. All molecules within
the channel were assumed to contribute equally to the fluorescence signal due to
the large depth of field of the 10x microscope objective used.
3.4.1.3 In situ Stability Measurements
Microfluidic channels were silanized with APTMS as described earlier and labeled
with the standard mixture of 2.5 µM AF555-NHS-ester and 5 mM sulfo-NHS-biotin.
The samples were then exposed to various conditions including 0.1 M NaOH
solution, water, and PBS buffer (pH 7.4). Each solution was tested in a separate
channel. Channels were exposed for six 10-minute intervals with each solution, and
between each interval the solutions were changed to HEPES buffer for fluorescence
imaging. All images were acquired at 1 s exposure time on the CCD. Each condition
was tested for a total of 60 minutes. All experiments were done in triplicate, and
the relative fluorescent intensities were normalized by the starting intensity.
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3.4.2 Fluorescence Imaging of Immobilized Proteins
In transparent microchannel systems, immobilized insulin fibrils, αS fibrils and
rAcGFP1 on the microchannel surfaces were detected by fluorescence microscopy.
• Immobilized insulin seed fibrils were exposed to ThT solutions (100 µM in
50 mM glycine buffer at pH 8.0) for 10 minutes, rinsed with the glycine buffer
and imaged with exposure time of 1 s.
• Immobilized αS fibrils were exposed to ThT solutions (100 µM in 50 mM
glycine buffer at pH 8.0) for 10 minutes, rinsed with the glycine buffer and
imaged with exposure time of 1 s.
• The rAcGFP1 proteins (λexcitation,max = 475 nm, λemission,max = 505 nm) that
were covalently immobilized on the microchannel surfaces, were imaged with
1 s exposure time after the protein solutions were rinsed.
For the imaging of all the three proteins, the Zeiss filter set 44
(λexcitation = 475 ± 40 nm, λemission = 530 ± 50 nm) was used.
3.4.3 SMR Kinetic Measurements
Torsional SMR chips, as presented in Section 1.2, were used to measure the
elongation kinetics of αS and insulin fibrils. The setup comprises an SMR chip with
a 3 × 8 µm microchannel resonator (Section 2.1.1), an oscillator circuit with optical
lever detection system (Section 1.3), and a pressure-driven fluid delivery system, as
shown in Figure 3.5.
Setup of the SMR chip
The SMR chip was assembled on a metal manifold and the in- and outlets of the
chip were aligned with the FEP tubes using a stereo microscope. The sealing of the
assembly was then tested. Initially, the natural frequency of the SMR device (in the
range of 1.2–1.5 MHz) was determined under gas flow. After the oscillator circuit
and the optical lever detection system (Figure 3.5) were adjusted, the microchannels
were filled with water. The system was then ready for further experiments.
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Figure 3.5: Experimental setup for the surface-based SMR measurements with an optical
lever detection system and a pressure-controlled fluid delivery system.
Fluid delivery
Flanged FEP tubes were used to connect the in- and outlets of SMR chips with
the running solutions, which were driven into the two large bypass channels under
pressure P1–P4, as shown in Figure 3.5. The fluid flow inside the resonator mi-
crochannel was then directed by changing the pressure P1–P4. The seed fibrils were
immobilized on the channel surface as described in Figure 3.3 of Section 3.3.6.1.
Glycine buffer was running continuously in the bypass channel R, while monomer
solutions were injected into the bypass channel L. Before the injection, the fluid in-
side the microchannel was directed from channel R to channel L by setting P2 higher
than P1. In the measurements, 10–30 µL monomer solutions were first injected into
the bypass channel L, the flow was then directed from channel L to channel R by
applying P3 < P1 but (P1 + P3) > P2. Due to the small pressure drop along the
bypass channel L, the 10 – 30 µL sample volume allowed kinetics measurements
for hours with pulse-free flow through the resonator channel at rates on the scale
of ca. 100 pL s−1. The monomer injection was conducted either directly from the
pressurized vials or using an autosampler. In addition, the temperature of the SMR
devices was regulated with a Peltier element. Depending on the composition of the
monomer solutions, the following elongation kinetic measurements were carried out:
• Concentration-dependent elongation of αS fibrils with monomer concentrations
of 0.03, 1, and 0.3 mg/mL;
3.4. BIOPHYSICAL DETECTION TECHNIQUES 57
• Concentration-dependent elongation of insulin fibrils with monomer concen-
tration ranging from 0.06 to 6 mg/mL;
• Temperature-dependent elongation of insulin fibrils at temperatures between
20 and 42 ◦C.
• Shear-effect on insulin fibril elongation at various flow rates. To evaluate
the fluid velocities through the 144 µm long resonator channel, microbeads
were added into the running solutions to measure the transit time. A sus-
pension of 1.5 µm NIST Microbeads was prepared at a concentration of 0.1%
in water and further diluted by 750 times. The suspension was ultrasonicat-
ed for 10 minutes to eliminate large aggregate particles and then mixed with
0.4 mg/mL monomer solutions. The transit time of the beads through the
resonator microchannels was detected and analyzed using correlation analy-
sis [177].
• Additive influence on insulin fibril elongation. Additives such as metal
ions (NaCl, ZnCl2, CaCl2 and MgCl2), aromatic compounds (PcTS and
Methylene blue) and natural products (ectoine and trehalose) were dissolved
in the insulin monomer solutions (0.4 mg/mL) at different concentrations, and
the kinetics were measured and compared with the kinetics obtained using
monomer solutions without additives.
Furthermore, dissociation measurements were conducted in the same manner by
injection of glycine buffer solutions under various conditions.
3.4.4 Fluorospectrometer Measurements
Fluorescence measurements for AF555-NHS-ester
The NanoDrop 3300 fluorospectrometer was used to measure the concentration of
fluorescent AF555 molecules cleaved from borofloat glass slides. To remove bound
fluorophores from the surface, the slides were incubated at room temperature
in 60 µL of 0.1 M NaOH. In addition, the fluorophore concentrations were
calibrated with known AF555-NHS-ester concentrations in 0.1 M NaOH solution.
Fluorescence emission was measured using the white light-emitting diode (LED)
excitation source (500–680 nm) of the NanoDrop with emission monitored at 565 nm.
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Fluorescence measurements for amyloid fibrils using ThT assay
ThT was dissolved in glycine buffer (50 mM, 100 mM NaCl, pH 8.0) with a stock
concentration of 100 µM. In the fluorescence measurements, glycine buffer was used
as the blank sample and 3 µL of fibril samples were mixed with 27 µL of ThT
solution. Since ThT dye undergoes a characteristic 120 nm red shift of its excitation
spectrum after binding specifically to amyloid fibrils [157], the fluorescence emission
of the mixture solutions was measured using the blue light-emitting diode (LED)
excitation source (470 ± 10 nm) of the NanoDrop with emission monitored at
506 nm. The position of the emission cursor was determined using the fluorescence
profiler module of the NanoDrop 3300 programm.
3.4.5 UV-VIS Spectrometer Measurements
Determination of AF555-NHS-ester concentrations
Blank measurements were performed using buffer solutions. Then 3 µL of AF555-
NHS-ester solutions were pipetted directly onto the pedestal and the absorption
spectra were recorded using Microarray module of the NanoDrop 2000c software.
By selecting AF555 dye, the spectrum cursors were placed at the wavelength of
650 nm and the concentrations were calculated automatically.
Determination of protein concentration
The blank measurements were done with buffer solutions and the pedestal surfaces
were then cleaned. Then 3 µL of protein (insulin or GFP) solutions were pipetted
directly onto the pedestal and the absorption spectra were recorded with the
Protein A280 module of the NanoDrop 2000c programm. The concentrations were
calculated automatically using the general form of the Beer-Lambert equation.
3.4.6 X-ray Photoelectron Spectroscopy Analysis (XPS)
Surface characterization by XPS was performed by Sven Hartwig at the Fraunhofer
Institute for Surface Engineering and Thin Films IST (Braunschweig). Open silicon
substrates were analyzed using a PHI 5500 Multi-Technique X-ray photoelectron
spectrometer system from Perkin-Elmer equipped with a Mg K X-ray source with
energy of 1253.6 eV. The elemental composition of samples was obtained from
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survey spectra, and collected at pass energy of 187.85 eV.
3.4.7 Electron Microscopy
Electron microscopy (EM) was used for morphological characterization of insulin
fibrils in the Facility of Electron Microscopy of the Max Planck Institute for
Biophysical Chemistry.
The insulin fibril solutions produced with initial 1 mg/mL monomer solutions
were firstly diluted by 50–100 times with either HEPES or glycine buffer to
achieve optimal resolution. The samples were then deposited on Formvar-coated
200 mesh copper grids. The samples were washed with water and stained with
freshly prepared 0.75% (w/v) uranyl acetate and examined on a Phillip CIME 12
transmission electron microscope, operated at 80 kV. The images were recorded
with a slow scan CCD camera.
3.4.8 Atomic Force Microscopy
Atomic Force Microscopy (AFM) detection was conducted to evaluate the density
of immobilized insulin seed fibrils on silicon substrates. The measurements were
conducted in the laboratory of Dr. Iwan Schaap (III. Physical Institute at University
of Göttingen).
Short insulin seed fibrils prepared as described in Section 3.3.3 were immobilized
on 3 mm x 6 mm silicon substrates at 25◦C following the protocols described
in Section 3.3.5 and Section 3.3.6.1. The samples were then imaged with a
Cervantes FullMode AFM System (Nanotec, Spain) using silicon cantilevers
(Olympus OMCL-AC240TS, tip radius 7 nm, Spring constant 1.8 N/m, resonant
frequency ca. 70 KHz). Force curves were performed on the substrate to estimate
the sensitivity (68 nm/V). The images were acquired at room temperature using
amplitude modulation by oscillating the cantilever at 65 kHz with an amplitude of
3.5–7 nm.
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Chapter 4




Robust protein immobilization on the microchannel surface is required for the
accurate kinetic measurements of amyloid growth by the surface-based SMR
approach. In this study, diverse immobilization techniques were evaluated: αS
fibrils were immobilized via electrostatic interaction using PLL; GFP and insulin
fibrils were immobilized via multi-step covalent coupling techniques.
In some immobilization techniques, many sequential steps are involved, and it
is difficult to validate the success of each of these steps directly inside the SMR
devices due to several challenges: (1) the inner walls are inaccessible and not
optically transparent; (2) the SMR measurements cannot resolve the deposition of
small functional groups; (3) re-assembly of SMR devices to the detection set-up and
the re-adjustment are required after certain steps such as vapor-phase deposition
of functional groups; and (4) clogging cannot be easily recognized in the SMR
detection system. Therefore, transparent microchannels were designed with similar
dimensions to the SMR microchannels as shown in Figure 4.1. The microchannels
were imaged using fluorescence microscopy to develop robust functionalization and
immobilization methods. Although the original goal was to develop the protocols for
SMR devices, the methods developed in this thesis also have their own significance
for other widely applied transparent microchannel systems.
PLL was initially used to immobilize αS fibrils due to the ease of use. In the
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Figure 4.1: Micro- (a) and nanochannels (b) for fluorescence microscopy.
transparent microchannels, seed fibrils binds efficiently to the surfaces. However, the
fluorescence detection in transparent microchannels did not allow further evaluation
of non-specific binding and stability. Alternatively, covalent immobilization methods
were also developed to achieve long-term stability. By comparing the quantities of
differently immobilized proteins, reliable binding assays were selected and adapted
to the measurements with SMR devices.
As presented in Section 2.2.1, multiple steps are often involved in the covalent
immobilization of proteins on solid supports. In this study, tri- and monoalkoxy-
silanes were used to introduce reactive amine groups to the hydroxyl-containing
surfaces, followed by further functionalization and immobilization of targeted
proteins. The robustness of the initial surface functionalization step, amino-silane
deposition, is very important for the success of the immobilization process. However,
applying established deposition methods to the microfluidic channels is not trivial,
partially due to the fact that the system is sensitive to the problems of clogging and
contamination by dispersion. Moreover, there is a lack of techniques to character-
ize the functionalization quantitatively in closed microchannels because of several
issues. First, the channel surfaces are inaccessible and the routine analysis tech-
niques for open-surface systems, such as AFM, SEM, XPS, ellipsometry, contact
angle measurement and labeling detection methods, cannot be readily applied
[28,46,58,79,173,180,199,248]. Second, biosensor-based approaches (e.g. SPR, OWS,
TLM and QCM) often require devices which have been specifically designed for the
measurements, although they can quantitatively monitor the surface reactions in
real-time [55, 145, 147, 163, 175]. Finally, the methods based on labeling techniques
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followed by cleavage, elution and detection steps are not practically applicable, since
all the steps need to be compatible with the microfluidic systems and the collected
eluent concentrations are much lower than the detection limit [194,248]. To address
these issues, two goals in this thesis were set to the development of robust deposition
methods and in-channel quantification methods.
Here a vapor-based deposition method is presented to allow robust in-channel
surface functionalization with amine groups for batch production. Furthermore,
the quality of functionalization, such as homogeneity, silane layer stability and
reproducibility, is assessed in situ using a novel fluorescence-based quantification
method. This novel imaging-based method measures directly the surface coverage
of functional groups inside assembled microchannels over a wide dynamic range.
Compared to the fluorescence detection that only qualitatively shows the presence
of the functional groups, the novel approach is readily applied to optimize the pro-
tocols, to maximize the surface density of functional groups and to eliminate errors
due to chip-to-chip surface variability. In addition, the measured surface density
of functional groups represents directly the reactive groups that are accessible and
available for further coupling.
Furthermore, subsequent functionalization using glutaraldehyde and
carboxymethyl-dextran were conducted to immobilize proteins. Green Fluo-
rescent Protein (GFP) was used to asses the binding capacities using different
immobilization methods. It was concluded that protein immobilization with
glutaraldehyde is a more promising method, which has been further applied to
study kinetics of insulin fibril growth in SMR detection systems in the following
chapter.
4.2 Electrostatic Immobilization of αS Using PLL
Coating glass/silicon surfaces with PLL has been widely used as the most economic
method to immobilize antibodies and DNA in microarray applications [48]. In
addition, the ease of use of PLL solutions allows surfaces to be functionalized within
one step with positive charge that can interact strongly with negatively charged
molecules. In the transparent microchannels, PLL was used to electrostatically
immobilize αS fibrils (pI 4.7) at pH 7.
The fibrils in PBS buffer at pH 7 were initially obtained as more than 2 µm
long fibrils (Figure 4.2 (b)) and ultrasonicated into short seed fibril of 146 ± 74 nm,
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as depicted in Figure 4.2 (c). After the seed fibrils were immobilized on the
PLL-coated channel surfaces (Channel "L" of Figure 4.3 (a)), ThT molecules were
injected into the microchannel that allowed imaging by fluorescence microscopy.
ThT, with structure shown in Figure 4.4 (a), is a fluorogenic label for β-sheet-rich
fibrils. When ThT was bound to the amyloid fibrils, the fluorescence intensity
was enhanced dramatically with excitation and emission maxima at approximately
440 and 490 nm (Figure 4.4 (b)). The significantly higher intensity of channel
"L" compared to the reference channel "R" in image (a) indicates that PLL can
efficiently immobilize αS-fibrils to the inner walls of the microchannels.
Figure 4.2: Electron micrographs of (a) αS monomers, (b) fibrils and (c) sonicated fibrils.
However, the stability of the fibrils on the surfaces could not be further assessed,
as any signal decrease could also be the result of the unknown photobleaching
rate of the ThT-labeled fibrils. Furthermore, quantitative evaluation of binding
efficiency (surface density of the immobilized fibrils) using PLL-modification was
not possible by this ThT-based fluorescence detection. It was highly possible that
the labeled ThT molecules could alter the fibril properties and thus further interfere
with the aggregation process. Evidence for this is shown in Figure 4.3 (b). In the
channel "L" of image (b-I), αS fibrils in solution were introduced to the native
surface of the microchannel and the subsequent ThT flow did not result in an
intensity increase. This is in agreement with the fact that negatively charged αS
fibrils do not bind to the negatively charged SiO2-surface. However, when the αS
fibrils were firstly mixed with ThT in solution and the mixture was injected into the
channel "L" of image (b-II), significant fluorescence signal was observed, indicating
that the fibrils stained with ThT remained on the native channel surface. This
observation evidently confirmed that the binding of ThT-molecules could promote
stronger interaction between αS and the native glass/silicon surface.
However, the binding mechanism of ThT to amyloid fibrils is poorly understood
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Figure 4.3: Fluorescence images showing αS-fibril immobilization on microchannel sur-
faces. All channel "R" are reference channels without surface functionalization, shortly
exposed to ThT solutions and then filled with buffer solutions. The injection sequences of
the solutions in channel "L" are respectively: (a) water - PLL - water - buffer - αS fibrils
- buffer - ThT - buffer; (b) buffer - αS fibrils - buffer - ThT - buffer (I) and buffer - αS
fibrils with ThT - buffer (II).
and the unknown binding stoichiometry of ThT to the fibrils does not allow
to correlate the revealed fluorescence intensity with the surface density of the
immobilized fibrils. Several studies on the mechanism of ThT-fibril interaction
have recently been reported. Among several hypotheses, the "channel" model
of ThT-fibril interaction suggests that ThT molecules are aligned parallel to
the long axis of the fibril and are likely located at the side-chain grooves of the
β-sheet structure [20,80,140]. However, the hypothesis can not provide any further
information to quantify the ThT-fibril binding stoichiometry.
PLL was further applied to bind proteins in the label-free SMR detection
systems (Section 5.1.2), and the stability using this immobilization technique for
kinetic measurements will be discussed in Section 5.1.2.
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Figure 4.4: ThT binding to amyloid fibrils. (a) Schematic of ThT structure and the
3D representation adapted from Ref. [20]. (b) Plot showing fluorescence emission of ThT
solution in the presence of αS fibrils and monomers. (c) Proposed "channel" model of ThT
binding to fibril-like β-sheets in Ref. [20].
4.3 Covalent Immobilization of Proteins
4.3.1 In-Channel Surface Functionalization
4.3.1.1 Vapor-Based Surface Functionalization with Aminosilanes
Amine functional silanes are among the most common and versatile coupling agents
for the functionalization of silicon and glass surfaces. Unfortunately, standard
silanization protocols that are developed for open surface systems often yield
poor reproducibility when translated to closed microfluidic systems. In this study,
aminosilanes were initially deposited by liquid-phase deposition using toluene. Using
fluorescence labeling with fluorogenic NDA molecules, the qualitative detection
often showed that the microchannels were clogged by self-assembled aggregation
of aminosilanes, as exemplified in Figure 4.5 (a). This problem was overcome by
vapor-phase deposition, which consistently modified both the large bypass channels
and the small 700 nm high nanochannels with a homogeneous silane layer. The
process used for vapor-phase silanization is described in Section 3.3.5.
4.3.1.2 Surface Quantification of Aminosilane Functionalization
A fluorescence-based method is demonstrated here to quantify surface functional
groups in closed micro- and nanofluidic channels in situ [258]. Fluorescence
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Figure 4.5: Surface modification with APTMS by liquid phase silanization (a) and vapor
phase silanization (b). Image (b)was taken by applying the new quantitative fluorescence
method.
microscopy is a widely applicable detection technique with the advantages of
high sensitivity and ease of use [58, 106, 112, 122, 199]. However, quantitative
interpretation of fluorescence from the channel surface is not trivial. Initially,
the amine functionalized surface was labeled with a pure solution of fluorescent
AF555-NHS-ester. As shown in Figure 4.6 (a & c), the fluorescence intensity
measured for labeling concentrations of 5 and 10 µM showed no change, suggesting
that surface saturation had been reached. Interestingly, under constant illumination
it was observed that the fluorescence intensity rose for the first ca. 500 s before
exhibiting a continual decrease. This behaviour might be attributed to the opposing
effect of self-quenching and photobleaching.
Fluorescence self-quenching has been reported to occur in a variety of systems, in-
cluding concentrated solutions and labeled proteins [44,79,271,277]. In microfluidic
systems, self-quenching of closely packed fluorescent molecules poses an important
challenge for accurate quantification of surface coverage. The potential to mitigate
self-quenching was explored here by controlling the distance between immobilized flu-
orescent molecules. To achieve this, a non-fluorescent competitor, sulfo-NHS-biotin,
was introduced into the AF555-NHS-ester solution to dilute the surface concentra-
tion of fluorescent molecules. Sulfo-NHS-ester was selected here not for its func-
tionality of biotin, but for its similar size, good solubility, and expectedly similar
reaction kinetics to AF555-NHS-ester.
The effect of limiting the fluorescent labeling density was clearly observed by
comparing the brightness of the three channels in Figure 4.6 (c). The left channel
was labeled using a solution of 5 µM AF555-NHS-ester in a background of 5 mM
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Figure 4.6: Fluorescence intensity profiles and concentration tables for microchannels
immobilized with (a) AF555-NHS-ester alone and (b) mixtures of fluorescent AF555-NHS-
ester and non-fluorescent sulfo-NHS-biotin. Solid lines represent the least squares fits
according to Equation 4.1. (c) Bright field and fluorescence images at time 0-300 s of three
microchannels silanized and labeld with AF555-NHS-ester (5 µM) and sulfo-NHS-biotin
(5 mM) (L); silanized and labeled with AF555-NHS-ester (5 µM) alone (M); unsilanized
and labeled with AF555-NHS-ester (5 µM) alone (R).
sulfo-NHS-biotin, while both the middle channel and the unsilanized right reference
channel were exposed to 5 µM AF555-NHS-ester alone. Fluorescence in the unsi-
lanized reference channel remained unchanged after incubation of AF555-NHS-ester
alone, indicating that non-specific adsorption was below the detection limit. At the
initial point of exposure, higher intensities were observed in the sparsely labeled
left channel compared to the middle channel. This relationship then reversed after
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prolonged illumination, indicating that under heavy labeling conditions quenching
was present.
Time course measurements of fluorescent intensity for various AF555-NHS-ester
and sulfo-NHS-biotin concentration ratios are shown in Figure 4.6 (b). The total
concentration of both species was maintained at 5 mM to minimize potential
differences in labeling efficiency. The fluorescence intensity decreased monotonically
with illumination time at low concentration ratios of AF555-NHS-ester (0.025%–
0.1%). However, for higher ratios (≥ 0.2%), a similar trajectory to Figure 4.6
(a) was observed and this non-monotonic behaviour became more evident as the
concentration of AF555-NHS-ester increased.
The observed non-monotonic trajectory of the fluorescence signals can be well
fitted with Equation 4.1 (established by Dr. Y.X. Mejia in the research group), which
stems from the interplay between photobleaching and self-quenching phenomena.





Here, the photobleaching, described in the first term with two decay half-life τph1 and
τph2 and parameters of A1 and A2, is suggested to follow multi-exponential behavior
in different environment, especially in the case of bound molecules [18,144,237,247].
In the second term, the fraction (A3) of quenched fluorophores that dequench with
time constant τdequench describes the intensity increase. The fitting results are listed
in Table 6.1 with fitting errors in Table 6.2 in the Appendix. It was concluded that
fluorophors were not quenched (A3 = 0) at concentrations lower than 3.5 µM. For
higher concentrations, A3 6= 0, quenching was present. The photobleaching could
be described as a single exponential decay with negligible A2-values because the
inclusion of A2 in fits provided no improvement in the fitting quality.
The mechanisms behind self-quenching are in general complex and highly
system-dependent [44]. Therefore, the full theoretical interpretation of the
quenching and photobleaching dynamics of surface bound fluorophores remains an
interesting problem and needs to be further studied not only in this system but also
for other labeling-based systems.
Fluorescence intensity as a function of fluorophore concentration was calibrated
using solutions of known AF555-NHS-ester concentrations inside the microchannels
as shown in the inset of Figure 4.7(a). Using this calibration, the measured den-
sity of AF555 molecules on the surface, σAF555,measured, was then calculated using
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Figure 4.7: Fluorescence intensity and the corresponding surface coverage of different
AF555-NHS-ester concentrations resulting from the competitive surface reaction. (a)
Including higher fluorophore concentrations. (b) Only with fluorophore concentrations
lower than 3.5 µM. (Inset) Calibration plot of fluorescence intensity versus concentration.
(c) Calculated total surface coverage of the microchannels using Equation 4.2. Error bars
indicate ± 1 standard deviation calculated from triplicate experiments.
Equation 4.2:
σtotal,measured =
σAF555,measured ∗ (cAF555 + cbiotin)
cAF555
(4.2)
where cAF555 and cbiotin are the labeling concentrations of AF555-NHS-ester and
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sulfo-NHS-biotin, respectively. This equation is based on the assumption that both
species undergo the same chemical reaction kinetics and the coupling processes are
reaction limited. First, both labeling species have the same NHS-ester coupling
chemistry. The rate constant of the aminolysis reaction determined experimentally
under similar pH and temperature conditions is reported to be 578 ± 13 M−1 s−1
[17,51,250]. As the rate determining step in this reaction is the nucleophilic attack of
the non-protonated amino-groups, it is expected that this rate should be very similar
for both labeling species. Second, the reaction rate of a diffusion-limited reaction is
estimated to be on the order of 109 – 1010 M−1 s−1, which is orders of magnitude
faster than the NHS-ester to amine reaction rate [17]. In the microchannel systems
of this study, the binding rate of the competing labeling species is thus not diffusion-
limited but reaction-limited, eliminating any possible effect the relative size of the
ligands could have.
As such, the amount of each bound species was well approximated by the rela-
tive concentrations of ligands in solution. However, in case that different coupling
chemistries are applied for the two species, the stoichiometry on the surface will not










Here, σdye and σcompetitor are the surface coverage of both products, cdye and ccompetitor
are the initial concentrations in solution, and kdye and kcompetitor denote the binding
rate constants to surface functional groups respectively. By knowing the ratio of rate
constants and measuring surface coverage of fluorophore molecuels σdye, the total
surface coverage can be determined using Equation 4.4:









In the absence of self-quenching at low fluorescence labeling concentrations, a
linear correlation between fluorescence intensity and surface coverage of fluorophore
was achieved, as shown in Figure 4.7(b). The small deviations from linearity are
likely due to variations in concentration during preparation caused by hydrolysis. In
contrast, the fluorescence intensity of surfaces labeled with mixture solutions that
had larger fluorophore fractions deviated significantly from linearity as depicted in
Figure 4.7(a).
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4.3.1.3 Quantification of Vapor-Deposited APTMS and APDMMS
Layers
The optimized fluorescence labeling method was applied to quantify the surface
coverages of aminosilane layers formed using APTMS and APDMMS.
By the APTMS deposition, an average total amine coverage inside the 3 × 8 µm
channel was obtained to be 55 ± 9 pmol/mm2 using Equation 4.2. This result was
independent of the exact ratio of AF-NHS-ester and sulfo-NHS-biotin for mixtures
in the range cAF = 1.25–3.5 µM as shown in Figure 4.7 (c). Similar results were
obtained when the experiment was conducted in nanofluidic channels with 700 nm
height. Based on the detection over a wide range of labeling concentrations, a
solution of 2.5 µM AF555-NHS-ester (the mole fraction of 0.05%) and 5 mM
sulfo-NHS-biotin was set as a standard mixture solution for direct quantification
and real-time monitoring.
The measured surface coverage was consistent with the reported amine den-
sity (3–150 pmol/mm2) for an open silicon surface measured after cleavage of
labeled molecules with UV/VIS detection [179, 181]. In contrast, by labeling with
fluorescent AF555-NHS-ester alone, initial intensities would only correspond to
0.12–0.14 pmol/mm2-values that were at least an order of magnitude less than the
true surface coverage. This illustrates the importance of controlling the density
of fluorophores for surface coverage quantification. To further corroborate the
reliability of the quantification method, vapor phase APTMS silanization was also
performed on open borofloat glass slides (∼240 mm2) and the surface coverage
was quantified again by cleaving the labeled molecules and detecting with a
fluorospectrometer. The total calculated surface coverage of 63 ± 21 pmol/mm2
was consistent with our microscopy-based measurements of labeled surfaces inside
the microchannels.
Assuming that the footprint of an APTMS molecule is around 1.9 nm2, a mono-
layer surface coverage would yield 0.87 pmol/mm2 [145]. Therefore, the aminosilane
coating on the surface of the microchannel was probably multilayered, making
some of the embedded amine groups inaccessible to surface labeling. As such, the
surface coverage measured with the fluorescence labeling method represented the
effective number of accessible reactive sites only. This could be quite advantageous
since practical applications of aminosilane layers typically require the validation of
binding capacity rather than surface coverage.
The fluorescence labeling method was further applied to quantify the surface
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coverage of aminosilane layers using APDMMS. Monoalkoxysilanes have been
suggested to form a self-assembled monolayer on glass/silicon surfaces with the
suggested advantage of better uniformity with shorter length of the interfacial
region compared to multilayers [69]. The surface coverage was quantified with the
proposed standard labeling condition identical to those used in the stability tests
(a mixture of 2.5 µM AF555-NHS-ester and 5 mM sulfo-NHS-biotin). The result
showed that APDMMS modified surface had 75% less accessible amine groups
bound compared to the APTMS surface (Figure 4.8).
Figure 4.8: Plot showing the total surface coverage for microchannel surfaces modified
with aminoalkoxysilanes APTMS and APDMMS. Error bars indicate ± 1 standard devia-
tion calculated from triplicate experiments.
4.3.1.4 In situ Stability Monitoring of Aminosilane Functionalization
The stability of amine functionalized microchannel surfaces under different solution
conditions was monitored using real-time fluorescence imaging. The microchannels
were labeled with the standard mixture of 2.5 µM AF555-NHS-ester, 5 mM
sulfo-NHS-biotin and then continuously rinsed with the HEPES solution (50 mM,
pH 6.5). Figure 4.10(a) shows the fluorescence intensity change of labeled amine
functionalized surfaces that were exposed to solutions of 1 x PBS (pH 7.4), pure
water, and 0.1 M NaOH (pH 13) and then imaged by temporarily changing the
solution in the channels to the HEPES solution. As AF555 is highly photo-
stable, fluorescence loss as cause for the fluorescence signal reduction can be ruled
out [56,200]. The fluorescence intensity remained stable for both PBS and water but
decreased quickly in the presence of 0.1 M NaOH with a half-life of ca. 16 minutes.
To corroborate the results of the stability test, identically prepared open
silicon surfaces were characterized with XPS analysis. Table 4.1 shows the relative
chemical composition of the APTMS modified substrates after incubation in
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Figure 4.9: XPS survey spectra of modified silicon substrates stability in solutions.
different solutions and representative survey spectra are shown in Figure 4.9.
Initially, plasma treated surfaces resulted in 50.5 at.% oxygen from the oxide layer.
At the same time, 24.5 at.% silicon was present, along with 24.8 at.% carbon and
negligible nitrogen. Surfaces functionalized with APTMS and incubated one hour
in PBS resulted in a significant increase in nitrogen to 1.5 at.% with an uncertainty
of ± 0.2 at.% (error estimated from background on clean silicon surfaces). In
comparison, surfaces treated with 0.1 M NaOH solution for 60 minutes resulted
in a substantial decrease in nitrogen content (0.1 at.%). As elemental nitrogen
was present only on the aminosilane deposited surfaces (Figure 3.2), the nitrogen
composition was used as indicator for amine groups. The results verified the
stability of the surface bound amine groups in PBS as well as their instability
in the basic NaOH solution. Furthermore, these results also confirmed that the
decrease in fluorescence intensity for surfaces exposed to NaOH in Figure 4.10
could be attributed to a degradation of the silane layer itself and not to the loss of
fluorophore emission.
The stability tests further confirmed the significance of the labeling with
the standard mixture for precise quantification. Figure 4.10(b) shows that the
fluorescence intensity of the densely labeled surface with pure fluorophore solutions
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Figure 4.10: (a) Time-dependent stability measurements of APTMS modified surface
rinsed with PBS buffer with pH 7.4 (red solid circle), pure water (blue solid triangle), and
0.1 M NaOH (black solid squre). Error bars indicate ± 1 standard deviation calculated
from triplicate experiments. (b)Fluorescence intensity change of APTMS modified surface
labeled (black solid squre) with the standard mixture solution and (green solid diamond)
with 5 µM AF555-NHS-ester alone.
Table 4.1: XPS atomic concentrations of APTMS modified surfaces after incubation in
different solutions. Atomic concentrations of nitrogen were used to indicate the presence
of amine functional groups. The error in N (at.%) is estimated at 0.2 at.% based on the
background of non-functionalized, plasma treated silicon surfaces.
Surface O (at.%) N (at.%) C (at.%) Si (at.%)
Si, plasma treated 50.5 0.2 24.8 24.5
Si-APTMS, PBS incubation 41.5 1.5 34.1 22.9
Si-APTMS, NaOH incubation 17.5 0.1 22.4 60.0
changed non-monotonically by exposure to NaOH solutions (green solid diamond).
The initial increase in intensity could be attributed to the combination of a
reduction in fluorophore number by NaOH attacking and an increase in dequenched
molecule number. After 40 minutes of exposure to NaOH, the intensity started to
drop below the starting level, however, the precise quantification using the new
method showed an over 80% fluorophore loss from the surfaces (black solid squares).
As such, the new quantification method is demonstrated here to be reliable to asses
the stability of functionalized surfaces.
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Evaluation of Regeneration Methods
Regeneration of functional groups on the surfaces allows to reuse the microchan-
nel and the SMR devices many times. In this study, regeneration was done by the
complete removal of the silane layer and restoration of hydroxyl groups. The flu-
orescence quantification method was applied to assess the success and efficiency of
surface regeneration strategies for sequential experiments on the same microfluidic
chip.
Plasma treatment, piranha and 0.1 N NaOH were used respectively to regenerate
the channel surfaces. Further functionalization resulted in regeneration of reactive
amine groups that were quantified by fluorescence labeling with the standard
mixture. The primany microchannels, which were packaged after production,
were set as the reference. As shown in Figure 4.11, only about one third of the
amine groups could be redeposited compared to the native surfaces, indicating that
plasma treatment was not sufficient to remove all the deposited amine groups from
previous functionalization. In contrast, the rinse with piranha and 0.1 N NaOH
solutions served to clean the surfaces of the used microchannels, and the amount
of the regenerated functional amine groups were measured to be comparable to
the reference. The surfaces cleaned with piranha solution were even redeposited
with ca. 10 pmol/mm2 amine groups more than the reference surfaces, possibly
due to the strong oxidation effect of the piranha solution. Although both of the
reagents can be used alternatively for transparent microchannels, the use of piranha
solution for SMR devices is more appropriate, since NaOH cleans the surfaces
under an etching mechanism and can cause leaking problems of the suspended SMR
resonators surrounded by vacuum.
Figure 4.11: Regeneration of amine functionalized surfaces detected by fluorescence quan-
tification.
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4.3.1.5 Protein Binding Capacity of Amine-Functionalized Surfaces
Using Glutaraldehyde Coupling
GFP proteins (rAcGFP1) were used to evaluate the binding capacity of vapor-
deposited APTMS layers using glutaraldehyde coupling. Non-specific adsorption
of GFP molecules to APTMS layers in the absense of a crosslinker was extremely
high as shown in Figure 4.13 (I), indicating that the negatively charged GFP
(pI 5.34 [166]) under physiological conditions could interact with the partially
protonated amine groups on the channel surfaces. In contrast, the surface of a
reference channel without aminosilane deposition, shown in Figure 4.13 (II), was
prevented from non-specific binding by passivation with BSA.
Glutaraldehyde was chosen to functionalize the amine groups on the surfaces
with aldehyde groups, as it has been reported to be one of the most efficient
agents to generate thermally and chemically stable crosslinking [149, 174, 273].
However, care must be taken due to the high reactivity and the complexity in
aqueous solution, because at least 13 possible polymeric forms under different
conditions (pH, concentration, temperature, etc.) have been found in equilibrium,
as partially shown in Figure 4.12 (I–VI) [174]. Different reaction mechanisms
could govern the process of amine-aldehyde-reaction, as shown in Figure 4.12.
In the SMR measurements, these large polymeric aggregates could easily block
the microchannels during the injection and thereby impede further experiments.
To address this problem, fresh glutaraldehyde solutions were centrifuged for at
least 10 minutes at 4◦C and only the supernatant containing maximal content of
monomeric molecules was introduced to the microchannel surfaces.
The binding capacity of the GFP molecules to the APTMS-functionalized
channel surfaces was quantified with fluorescence measurements in situ. The
calibration showed the linear correlation between the fluorescence intensity and
GFP concentrations in the microchannel (Figure 4.13 inset). Figure 4.13 (a, III)
shows that GFP molecules bind efficiently to the glutaraldehyde-functionalized
surfaces. The surface density of the immobilized GFP was calculated to be
1.2 ± 0.5 pmol/mm2.
The stability of immobilized GFP molecules was tested by running buffer
solutions inside the microchannels. The surfaces were exposed to the fluorescence
illumination only while taking images with exposure time of one second. The plot
of Figure 4.14 shows that ca. 90% of the initial intensity remained at the same level
after 60 minutes rinsing. The 10% signal reduction might arise from the photo-
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Figure 4.12: Schematic showing possible monomeric and polymeric structures (I–VI) of
glutaraldehyde in aqueous solutions and the subsequent reaction mechanisms with amine
groups of targeted proteins.
bleaching of the GFP molecules, since the signal after 16 h was kept at the same
level with the signal detected at 1 h. In comparison, 40% of the non-specifically
adsorbed GFP molecules were rinsed off the surface within 5 minutes as shown in
Figure 4.14 (black squares), clearly indicating the weak interaction between the
GFP molecles and the surface amine groups. The results validated the stability
of the immobilized GFP proteins by using glutaraldehyde as the coupling-agent.
Based on this, the method can be reliably applied for immobilization of amyloid
fibrils.
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Figure 4.13: Fluorescence images (a) and intensity plot (b) of immobilized GFP on the
APTMS-treated (I), BSA-passivated (II), APTMS and GA-treated (III), and APTMS-
GA-treated and ethanolamine-passivated (IV) surfaces. (Inset) Calibration of fluorescence
intensity with various GFP concentrations.
4.3.1.6 Surface Functionalization with Carboxymethyl Dextrans
In this study, carboxymethyl(CM)-dextran was also used to further functionalize the
APTMS-modified surfaces. CM-dextran of 150 kDa molecular weight was deposited
at 40 mg/mL in PBS buffer (pH 8.0) in a mixture of EDC and NHS solutions.
The initial motivation for using CM-dextran was to achieve higher capacity of
immobilized proteins in the voluminous hydrogel matrix. As a biocompatible and
hydrophillic polymer, dextran has been suggested to be a preferred linker for protein
immobilization [72, 122, 257, 274]. In addition, the anti-fouling material can also
prevent non-specific binding. All these properties have been exploited to couple
biomolecules in the field of Biacore chips and microarray systems [246]. Here, GFP
was also used to assess the binding efficiency.
Two coupling protocols were tested on the CM-dextran modified surfaces, as
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Figure 4.14: Plot showing the stability of non-specifically adsorbed GFP proteins (black
squares) and covalently immobilized GFP proteins using glutaraldehyde (red dots) on the
APTMS-modified surfaces.
shown in Figure 4.15:
• (I) CM-dextran that was commercially obtained was activated with
EDC/NHS. Due to the voluminous structure of the matrix, the carboxyl
groups only partially reacted with the surface amine groups. The remaining
activated carboxyl groups were then used to link GFP molecules (protocol I-
A). Alternatively, sodium chloroacetate was used to further enrich the carboxyl
groups of the dextran matrix by reacting with its hydroxyl groups (protocol
I-B). The proteins were then coupled to the EDC/NHS-activated carboxyl
groups in both protocols.
• (II) After the deposition of CM-dextran on the channel surfaces, sodium
periodate was used to direct the oxidation of the cyclic dextran ring to dialde-
hyde groups, which could form Schiff’s base with amine groups of the proteins.
Further reduction using sodium cyanoborohydride stabilized the coupling.
The binding of GFP proteins to the CM-dextran surfaces was generally not as
efficient as expected. As shown in Figure 4.16, the intensity of channel "L" following
method (I-A) of image (I-A) was much lower than channel "R" adsorbed with
GFP non-specifically and channel "L" of image (II) where GFP was coupled to the
aldehyde groups generated using glutaraldehyde. The low signal indicates that not
many carboxyl groups of CM-dextran were left for GFP coupling. In channel "M"
of image (I-B), higher intensity was expected since the use of sodium chloroacetate
with method (I-B) could theoretically generate more carboxyl groups. However,
only comparable intensity to the untreated CM-dextran layer was measured in this
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Figure 4.15: Schematics for immobilization of GFP proteins (presented as R-NH2) to the
carboxymethyl-dextran hydrogels on the microchannel surfaces.
channel. In channel "M" of the image (II), the low fluorescence intensity did not
show efficient GFP binding to the CM-dextran modified surface that was oxidized
by sodium periodate. The signal in channel "M" was at the background level
when GFP was bound to aldehyde groups generated by using glutaraldehyde in
the channel "L" of image (II). In general, despite the many advantages of protein
immobilization on the biomimetic dextran-modified surfaces, more studies are
required to develop a reliable and consistent way for higher binding capacity and
efficiency.
4.3.2 Immobilization of Insulin Fibrils
So far, the development and the characterization of in-channel surface functionaliza-
tion have been presented here for reliable protein immobilization. The techniques
can now be applied to the primary objective of this study, the immobilization of
amyloid fibrils. Since the last two decades, insulin aggregation has been intensively
studied since the amyloid-like insulin fibrils have been found to be associated
with diseases such as injection amyloidosis. Moreover, insulin fibrillation occurs
frequently during insulin production and long-term storage [25,63,116]. Due to the
simplicity of insulin monomers that contain two short polypeptide chains with one
intramolecular and two intermolecular disulfide bonds, as shown in Figure 4.17,
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Figure 4.16: Fluorescence images of immobilized GFP proteins in APTMS-modified mi-
crochannels using CM-dextran alone (I-A, channel "L"), CM-dextran and sodium chloroac-
etate (I-B, channel "M"), glutaraldehyde (II, channel "L"), CM-dextran and sodium peri-
odate (II, channel "M"), BSA as reference channels (I-A, channel "M"; I-B, channel "L"
and "R"; II, channel "R"). The channel "R" in Image (I-A) shows non-specific adsorption
of GFP on APTMS-modified channel surfaces.
many studies have been carried out and in vitro fibril formation is relatively easy
to achieve and control. However, in microfluidic systems, optimal conditions need
to be established to produce fibrils ideally with homogeneous size distribution.
Furthermore, the biofunctional properties of the immobilized insulin molecules on
the microchannel surface need to be retained.
Figure 4.17: Insulin structure with two polypeptide chains.
Size Distribution of Insulin Fibrils
Preparation of insulin seed fibrils with uniform size distribution is of great impor-
tance for the kinetic measurements of the fibril growth, since the resultant average
growth rates are representative for a defined ensemble of fibrils. Furthermore, the
uniform seed fibril length can be used to estimate the number concentrations of
the fibrils immobilized on the surface of the SMR microchannel (Section 5.2.1).
Rate constants can thereby be accurately determined as the number of monomers
binding to the fibril ends per time.
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In many protocols used to prepare insulin fibrils in vitro, monomers were
dissolved in HCl solution (10 mM) at pH 2 and with high salt concentra-
tions [25, 38, 107, 120] or glycine buffers at pH 2 [9]. Since glycine contains amine
groups in its structure and will compete with insulin fibrils to react with the
surface aldehyde groups, it cannot be used as the buffer solution for immobilization
purposes. Initially, insulin aggregation was done in 25 mM HCl solution (pH 1.6,
100 mM NaCl) at 37◦C for more than two days until the aggregation was complete
as validated with the ThT assay. The solutions turned cloudy with fibrils, and
electron microcopy showed that long fibrils clumped into large aggregates, as shown
in Figure 4.18 (b). These large clumps could easily clog the microchannels and
therefore are not applicable to the detection systems. This problem was solved by
dissolving the insulin monomer in 10 mM HEPES at pH 2.0. The resultant long
fibrils in Figure 4.18 (c) were dispersed in the solution which looked clear even after
the aggregation was done. Furthermore, ultrasonication was used to break down
the preformed fibrils into short fibrils, as the approach has been reported to produce
monodispersed fibrils of minimum size [42]. In this thesis, preformed long fibrils
were ultrasonicated for 150 minutes at 4◦C. The obtained short seed fibrils were
then filtered with a 0.22 µm membrane filter. 70.3 ± 11.5% seed fibrils were retained
in the filtrate for immobilization. Using EM (Figure 4.18), the average length of
the obtained fibrils was evaluated to be 97.6 ± 20.1 nm and the average width to
be 12.3 ± 0.8 nm. The width value implies that a mature fibril consists of two
protofibrils that are ca. 5–7 nm wide [1, 119]. As the mass-per-length value of the
fibrils with two protofibrils has been determined to be 2.85 ± 0.35 kDa/Å [43,116],
the average buoyant mass of a single short fibril was calculated to be 1.2 ± 0.4 ag.
Immobilized Insulin Fibrils
The solutions of short insulin fibrils were immobilized to the microchannel surfaces
following aminosilane and glutaraldehyde functionalization and stabilization. The
immobilized fibrils were then labeled with ThT molecules to allow imaging by
fluorescence microscopy. In the small 2 x 2 µm microchannel and the right
bypass channel shown in Figure 4.19, the short insulin fibrils were observed to be
homogeneously distributed on the surfaces. The comparable fluorescence intensities
in both channels indicate that there was no difference in binding efficiency in both
channels. The flow of the fibril solution was unobstructed, and the flow direction
could be controlled without clogging. In the left bypass channel, the surface
was passivated by coupling ethanolamine instead of insulin fibrils to the reactive
aldehyde groups. After ThT solutions were filled in the channel followed by rinsing
84 CHAPTER 4. SMR SURFACE MODIFICATION
Figure 4.18: Electron micrographs of (a) insulin monomers, (b) insulin fibrils grown in
HCl-NaCl solution, (c) insulin fibrils grown in HEPES solution and (d) sonicated insulin
fibrils.
with the buffer solution, the fluorescence intensity was kept at background level,
indicating efficient prevention of the non-specific fibril adsorption.
Figure 4.19: Fluorescence image of immobilized insulin seed fibrils inside the small mi-
crochannel and the right bypass channel (a). The left bypass channel modified with APTMS
and glutaraldehyde was passivated from non-specific binding using ethanolamine. Plot (b)
shows the intensity increase detected by labeling with ThT compound when the seed fibrils
grow in the presence of monomers.
To be sure that the immobilization on the surface did not fundamentally change
the structure of the fibrils and affect amyloid growth, monomer insulin solutions
were introduced to the immobilized fibrils and the grown fibrils were labeled
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again with ThT to give a detectable fluorescence signal. As plotted in Figure
4.19 (b), both experiment replicas show that the immobilized fibrils were able
to grow, indicating that the functionality of the fibrils was preserved. However,
as discussed in Section 4.2, quantitative interpretation of the growth kinetics
is impossible by fluorescence detection using ThT-binding assay due to the un-
known binding stoichiometry and the risk of interfering with the aggregation process.
The covalent protein immobilization approach developed in the transparent
microchannel systems using fluorescence microscopy can be readily applied to the
SMR detection system. The stability and reproducibility tests of this approach is
presented and discussed in the next chapter.
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Chapter 5
Kinetic Measurements of Amyloid
Fibril Growth using SMR
5.1 Introduction
Having established protein immobilization techniques using transparent microchan-
nels and fluorescence microscopy, the methods were applied to the SMR detection
system for the precise kinetic measurements of amyloid growth. The study initially
focused on the elongation process using the proteins αS, that is closely related
to Parkinson’s disease, and insulin that is relevant for diabetes patients. In this
chapter, achievements with the novel surface-binding-based SMR approach in
characterization of fibril immobilization density, precise measurements of elongation
kinetics, studies on the underlying mechanisms, thermodynamics and effects of
environmental factors, as well as screening for potential inhibitors are presented.
In the first two parts of this chapter, the feasibility and the reliability of the
kinetic measurements were tested, making use of both electrostatic and covalent
immobilization techniques. Nonspecific binding, stability of immobilized seed
fibrils, and reproducibility were evaluated and compared using both immobilization
methods. The most reliable method was selected and applied for further accurate
quantitative measurements of elongation kinetics.
Subsequently, elongation kinetics were studied using insulin as a model system
for the fibrillation process. Insulin has a very strong propensity to form fibrils
and its amyloid deposits have been found in patients with type II diabetes after
continuous insulin infusion and after repeated insulin injections. In addition, insulin
aggregation is a serious problem in the protein production, storage and delivery
processes [188]. It has been frequently reported that low pH of 1–3 in the insulin
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purification steps and agitation during transportation can trigger aggregation. Due
to the similarity of amyloid fibrils formed by different proteins, the results are of
significance for many systems other than insulin.
As presented in the previous Section 1.1.2, there is significant experimental
evidence demonstrating that the fibril elongation process is a bimolecular reac-
tion [39, 105, 138, 146, 197]. The elongation rate dN
dt
can therefore be described by
Equation 5.1 with the number N of monomer molecules bound to the fibrils, the
absolute rate constant k, the number of the fibrils immobilized on the surface NFibril
and monomer concentration in solution cMonomer.
dN
dt
= k ∗NFibril ∗ cMonomer (5.1)
The SMR measurements allow determination of the elongation rates and of the
absolute rate constants, which are fundamental characteristics of the process. As
discussed in Section 1.2, the kinetics of amyloid growth is conventionally measured
in solution and depends strongly on the presence of seed fibrils, concentration of
monomers and whether the solutions are stirred [146]. Quantitative interpretation
of the results is extremely challenging, as the concentrations of fibrils are unknown
and the absolute growth rates therefore cannot be evaluated. In the surface-based
SMR measurements, the precise determination of the kinetics at various concentra-
tions and temperatures enables deeper understanding of the mechanisms and the
thermodynamics of the explored elongation process.
Here, the surface-based SMR approach is also demonstrated to be a reliable
label-free inhibitor screening method for amyloid growth. Importantly, the SMR
measurements can also be used to screen for fibril dissociation by monitoring
degradation of surface fibrils in the presence of chemical compounds or at various
pH and temperature. Based on both applications, the SMR measurements could be
of great therapeutic and preventive importance.
5.1.1 Sensitivity of Surface-Based SMR Measurements
The correlation between the subtle change in the resonator mass and the frequency
shift was determined by measuring the frequency shifts of sodium chloride solutions
at different concentrations (2–20 mM). The density variation of the fluids arises
from dissolving different amounts of NaCl in water and was estimated for different
salt concentrations using a table of fluid density vs. NaCl concentration [159]. The
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slope of the linear fit in Figure 5.1 shows that a density change of 1 mg/cm3 resulted
in a frequency shift of 76.11 ± 1.19 Hz. Based on Equation 2.11 in Section 2.1.1,
the density sensitivity Sρ was determined to be 53979 ± 844 ppm/(g·cm−3) by
using a torsional SMR containing a 3 µm high and 8 µm wide channel and having
a resonance frequency of ca. 1.41 MHz. For surface-based measurements with this
device, 1 Hz frequency shift was correlated to be a change in surface density of
1.43 ± 0.02 ng/cm2 (Equation 2.11 in Section 2.1.1). This value was later used to
estimate the density of amyloid seed fibrils immobilized on the channel surfaces.
Figure 5.1: Calibration of the resonance frequency shift as a function of fluid density.
5.1.2 Comparison of Reproducibility and Stability Using
Electrostatic and Covalent Immobilization Techniques
In this study, accurate determination of elongation rates requires stable seed fibril
immobilization on the microchannel surface, providing known and consistent fibril
densities throughout the measurements.
In the SMR measurements, the PLL-based electrostatic immobilization tech-
nique was initially applied and the growth of the adsorbed αS-fibrils on the
microchannel surface was monitored when they were exposed to monomer solutions.
A frequency decrease in a frequency-time-plot indicates a mass increase of the
resonator as a result of molecules attaching to the microchannel surface. As
shown in Figure 5.2(a), 146 ± 74 nm-long fragmented αS seed fibrils, as imaged
using EM (Figure 4.2 (c) in Section 4.2), were immobilized onto the PLL-coated
surface by following a procedure similar to the one applied in the transparent
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microchannels. This resulted in a frequency decrease of ca. 25 Hz, corresponding
to a fibril surface density of 38.6 ± 0.5 ng/cm2. The immobilized fibrils were then
brought into contact with a running monomer solution (20 µM in HEPES buffer
at pH 6.5) for 30 minutes. The frequency decreased continuously, indicating fibril
growth in the presence of monomer molecules (Figure 5.2 (a) and (b, blue line)).
This was also the first proof-of-principal that the surface-based SMR measure-
ments could be applied to monitor amyloid elongation. By measuring the frequency
difference under buffer before and after the injection of monomer solutions over time,
the average growth rates can be estimated as total amount of mass increase per time.
A significant disadvantage of the PLL-based immobilization is the high level of
non-specific binding of αS monomers. This limits the application of the method for
further accurate kinetic measurements. As plotted in Figure 5.2 (b, black line), a
frequency decrease of 19 Hz clearly indicates that monomer molecules attach to the
channel surfaces in the absence of seed fibrils. In comparison, 30 minutes flow of the
monomer solution over the fibril surfaces resulted in a frequency decrease of 65 Hz
(Figure 5.2, plot a and b with blue line). Although the frequency decrease due
to fibril elongation is over three times larger than that resulting from non-specific
adsorption, it is difficult to distinguish the proportion of the non-specific signal
from the elongation signal. The results can therefore not be used to quantify the
elongation on-rates.
Moreover, as the monomer concentration was kept constant by continuous flow,
the fibril growth was expected to be at a constant rate according to the fibril
elongation kinetics presented in Equation 5.1. However, a non-linear growth of the
fibrils was observed here. The non-linear growth could arise from the combined
effect of elongation and the continuous loss of the immobilized fibrils off the surface
due to the unstable immobilization, although this instability was not recognized in
the detection with the transparent microchannel system presented in Section 4.2.
To reduce the non-specific-binding of monomers onto the surface, PLL-grafted-
CM-dextran was deposited in the SMR measurements. The subsequent seed fibril
immobilization was done by using EDC/NHS-activator as introduced in Section
2.2.1. Using this immobilization approach, non-specific binding of αS monomers
was efficiently suppressed due to the hydrophilicity of the dextran matrix as shown
in Figure 5.2 (c, black line). A frequency shift of only 19 Hz after 30 minutes in
the presence of 20 µM monomer solution (c, blue line) showed that the polymeric
dextran matrix did not increase the surface density of the seed fibrils for monomer
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Figure 5.2: SMR measurements of binding of αS monomers to PLL-coated surfaces or
PLL-immobilized fibrils (a); non-specific monomer adsorption (b); and binding of αS to
the surface using PLL-grafted-CM-dextran modification and EDC/NHS activation (c).
addition. Similar to the elongation monitoring on PLL-coated surfaces, the
non-linear fibril growth over the extended experiment time is again indicative for
unstable fibril immobilization on the surfaces.
To confirm that the observed non-linear growth of the fibrils immobilized using
PLL and PLL-grafted-CM-dextran was caused by the unstable immobilization, the
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sequence of elongation measurements with three αS monomer concentrations (0.3,
1 and 30 mg/mL) was repeated multiple times and the resulting frequency shifts
were compared. As shown in Figure 5.3 (a), the reproducibility experiment of the
PLL-linked fibril elongation shows an approximately 30% systematic reduction of the
frequency signals from experiment sequence E1 to E4, indicating that fewer fibrils
were available for the elongation compared to the previous measurement under the
same condition.
A similar experiment was conducted with the αS fibrils immobilized using
PLL-grafted-CM-dextran. By repeating the concentration sequence, a continuous
fibril loss from the surface was also revealed, as shown in Figure 5.3 (b). As such,
it is concluded that the electrostatic immobilization technique is generally not
sufficient for the purpose of accurate kinetic measurements.
In comparison to the electrostatic immobilization, the stability of insulin fibril
immobilization was also tested using the established covalent immobilization
techniques with the aminosilane APTMS and glutaraldehyde as coupling agents.
Here, three insulin monomer solutions (0.6, 2 and 6 mg/mL) were injected into the
resonator microchannel in sequence for 5 minutes respectively. By repeating the
experiment set for two more times, the frequency decrease as a result of monomer
binding to the immobilized fibrils was unchanged. This is clearly shown in Figure
5.3 as the time courses of the frequency signals overlapped with one another. As
such, it can be concluded that the insulin seed fibrils were stably immobilized on
the surfaces over the extended experiment time (ca. 2 h).
The comparison of the three reproducibility tests using different protein
immobilization techniques demonstrates that only covalently immobilized fibrils
are stable on the surface under continuous flow conditions and can thus be reliably
applied in the SMR measurements for the quantitative kinetic studies.
In addition to the reproducibility tests, the long-term stability was verified by
monitoring the growth rates of the same ensemble of the immobilized fibrils with
the monomer solutions under the same condition (0.4 mg/mL, 37◦C) for one week.
The plotted results, presented in Figure 5.4, show comparable rates over time
and corroborate the stable immobilization of the fibrils. The small variation was
possibly due to the small concentration variation of the freshly prepared monomer
solutions.
Since both reproducibility and stability tests confirmed the reliability of the
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Figure 5.3: Reproducibility of the fibril elongation measurements by SMR using different
immobilization techniques with PLL (a), PLL-grafted-CM-dextran (b) and aminosi-
lane/glutaraldehyde (c).
SMR measurements, the detection system is demonstrated to be applicable for
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Figure 5.4: Stability test by measuring fibril growth with 0.4 mg/mL monomer solution
at 37◦C for one week.
quantitative measurements with many different conditions.
5.2 Elongation Kinetics of Covalently Immobilized
Insulin Fibrils
5.2.1 Surface Density of Immobilized Insulin Seed Fibrils
Surface densities of covalently immobilized insulin seed fibrils were quantified in
situ by measuring the frequency shift before and after the fibril solutions were
introduced to the functionalized channel surface. The estimated quantities were the
basis for determination of the elongation rates and the rate constants. In the SMR
measurements, the immobilization steps that started with the aldehyde-containing
surfaces were recorded, as shown in Figure 5.5. The fast solution change from
water to the HEPES buffer (pH 2.0) resulted in a sudden frequency decrease due
to a density increase. The low pH running buffer was used here to retain the
same pH environment of the seed fibrils and to avoid possible fibril precipitation
by passing over the isoelectric point at pH 5.5 [89]. Insulin seed fibrils were then
introduced to the microchannel surface and the fibrils saturated the surface within
15 minutes. By comparing the signals with water before and after the seed fibril
immobilization, a frequency decrease of 71.3 ± 8.6 Hz corresponded to a fibril
density of 734 ± 89 molecules/µm2. Here, the average mass of a single fibril
was estimated to be 1.2 ± 0.4 ag (mass-per-length: 2.85 ± 0.35 kDa/Å [116]),
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characterized by EM in Section 4.3.2. The fibril-fibril distance was therefore
determined as 37 ± 13 nm. The surface of the SMR chip was regenerated and the
fibril immobilization was repeated at least four times. The error of regenerated
surface densities of the insulin fibrils was ca. 10%, indicating that the developed
immobilization technique was highly reproducible.
Figure 5.5: Immobilization of insulin seed fibrils on SMR microchannel surfaces.
To reconfirm the surface density of immobilized seed fibrils on the channel
surfaces, open-surface samples were prepared with silicon substrates and de-
tected by AFM. There were two differences in immobilizing the fibrils: first,
the temperature was kept at 25◦C instead of 37◦C; Secondly, open surfaces
were incubated in solutions of fibrils and coupling agents with defined volume
under stirring. However, the obtained surface densities should be comparable,
as all the concentrations were sufficient to fully saturate the surface area of the
substrates. Densely immobilized fibrils were shown in the AFM image (b) of
Figure 5.6. An aminosilane-modified Si-substrate without fibril immobilization is
shown for comparison in image (a). By counting the fibril peaks in the profile of
image (c) along the drawn 2 µm-long line, the fibril-fibril distance was determined
to be 46 ± 7 nm, which is consistent with the value obtained by SMR measurements.
5.2.2 Determination of Absolute Rates of Insulin Fibril
Elongation by SMR
The elongation kinetics of covalently immobilized insulin seed fibrils were measured
when the resonator microchannel was filled with a fresh monomer solution (1 mg/mL,
glycine buffer, pH 2.0) at 37◦C. The linear signal decrease in Figure 5.7 (red line)
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Figure 5.6: AFM images of APTMS-modified Si-substrate (a) and immobilized insulin
seed fibrils on the Si-substrate surface (b). (c) Profile showing topography of fibril-
deposited Si-substrate along the line drawn in (b).
over time indicates that the fibrils grow at a constant rate, as expected with the
expression in Equation 5.1. Reference experiments were taken to test the non-specific
adsorption of monomers to the passivated channel surfaces. The channel surfaces
were first functionalized with aminosilane and glutaraldehyde, and glycine molecules
instead of seed fibrils were then introduced to couple with the reactive aldehyde
groups. As shown in Figure 5.7 (black line), the exposure of the passivated surface to
monomer solutions for half an hour did not cause any significant frequency decrease,
indicating the low non-specific monomer binding. The elongation rate can be directly
obtained either from the slope of the frequency-time-plot or by evaluating the total
frequency change over the measurement time. Under the given condition, the value
of the frequency change rate −df
dt
was measured to be 2.32 ± 0.23 Hz/min. As the
surface density of immobilized fibrils was determined to be 734 ± 89 molecules/µm2
(as presented in previous Section 5.2.1), the change of the frequency corresponded
to an averaged mass increase rate of 159.92 ± 15.85 fg/min. Normalized by the
number of immobilized seed fibrils NFibril, this yielded an approximate elongation
rate of 12.2 ± 1.2 monomer molecules per fibril per minute and a rate constant
k = (1.2 ± 0.1) ×103 M−1 s−1. This indicates that one monomer attaches and binds
to a seed fibril every 4.9 ± 0.5 s on average.
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Furthermore, each seed fibril was assumed to consist of two twisted protofibrils
detected by EM (4.3.2) and each monomer contributes to a 0.48 nm length increase
along the fibril axis. Therefore, the half-hour fibril growth resulted in a length in-
crease of approximately 88 nm in total. The length increase was negligible compared
to the 3 µm by 8 µm microchannel dimension, implying that the fibril growth did
not affect the fluid flow in the channel. As shown in Figure 5.7, the unchanged
slope clearly verified the independence of the growth rate on the fibril length. This
independence is important for further quantitative measurements under different
conditions, as the rate comparison can be performed with an identical ensemble of
fibrils within minutes and the parameters that change the rates can be studied. In
addition, the non-specific adsorption of monomer molecules to the functionalized
surfaces could be efficiently prevented.
Figure 5.7: Plot showing seed fibril growth with 1 mg/mL monomer solution for
30 minutes and non-specific binding of monomers on passivated surfaces.
Knowles et al. measured the elongation rate of bovine insulin using QCM
detection at room temperature [138]. At the same monomer concentration of
1 mg/mL, the monomer binding time was reported to be 3.1 ± 1.2 s. The binding
time is slightly shorter but within the same order of magnitude with the value
obtained by SMR. The slightly faster elongation observed by QCM can be explained
by the fact that bovine insulin is more prone to form fibrils than human insulin due
to different amino acid residues in three positions [187]. Differences in temperature
and buffer could further explain the rate difference.
Figure 5.8 shows that the measurements of the elongation rate constants took
less than 5 minutes with three different monomer solutions, consuming ca. 10–30 µL
sample volume. However, the equivalent flow-cell volume of the SMR devices was
less than 10 pL — 3–6 orders of magnitude less compared to that of conventional
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biosensors such as QCM and SPR. The low sample consumption was achieved
by simultaneously pressurizing the in- and outlet of a bypass channel, slowing
down the flow rate in the bypass channel, as presented in Section 3.4.3. Figure
5.8 shows successive measurements of elongation rates on the same fibril ensemble
at three different concentrations with (b) and without (a) concentration-induced
fluid density change subtracted. The plot (b) shows that the slope or the growth
rate increased with the monomer concentration. More studies of the effect of
environmental factors on fibril elongation kinetics are described in Section 5.3.1.
Figure 5.8: SMR measurements of seed fibril elongation with (a) and without (b) fluid
density change.
5.3 Effect of Solution Composition, Temperature
and Flow on Insulin Fibril Elongation
In the search for the fundamental mechanisms and the thermodynamic parameters
of the amyloid fibril elongation process, effects of various environmental factors on
the elongation rate constants were explored. The tested parameters were focused on
the following categories:
• Solution composition. The kinetic dependence on monomer concentra-
tion was explored. Moreover, additives such as metal ions, natural products
and small aromatic organic compounds were screened. Many of the additives
have been suggested to be potential drug candidates to treat amyloid-related
diseases as introduced in Section 1.1.3.
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• Temperature. Combined with the measurements with various monomer
concentrations, mechanistic models were established and the thermodynamic
parameters were measured.
• Flow. The effect of mechanical shear force in the microchannel system was
studied.
It is noteworthy that all measurements here were conducted in solutions at pH
2.0 due to the reduced solubility of insulin monomers at higher pH values. As shown
in Figure 5.9, 0.4 mg insulin monomers were dissolved in 1 mL buffer solution at
pH in the range of 2.0 to 7.0. The solutions were filtered with 0.22 µm membrane
filters and the filtrate concentrations were determined by measuring the absorbance
at 280 nm. The plot shows that more than 60% monomer molecules were filtered out
when the pH was above 4.5 and the monomer solubility decreased with higher pH
values. Therefore, all the monomer solutions in the elongation experiments were set
to pH 2.0 in order to lower the risk of data analysis with uncontrolled concentration
parameter and the eventually possible clogging problems in the SMR microchannel
systems.
Figure 5.9: Solubility test of insulin monomers at various pH values detected by UV
absorption detection at 280 nm. Insulin was initially dissolved at the same concentration
of 0.4 mg/mL in all buffer solutions at various pH.
5.3.1 Insulin Elongation Kinetics as a Function of
Temperature and Monomer Concentration
Having established the robustness of the method, the concentration-dependence of
the growth rate was examined with monomer concentrations over three orders of
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magnitude (0.06–6 mg/mL) to probe the elongation process by which monomers
were incorporated into growing fibrils. The elongation rates of all the solutions
were also measured at different temperatures (20–42◦C), so that the characteristic
thermodynamic parameters could be obtained. The measured changes in resonance
frequency and the corresponding absolute elongation rates dN
dt
were summarized in
Figure 5.10. As shown in plot (a), a rate increase with temperature was clearly
observable. For example, the results showed a ca. 3.5 times increase in elongation
rate as the temperature was changed from 25◦C to physiological temperature of
37◦C. At a given temperature, the elongation rate increaseed non-linearly with
the monomer concentration. The rate increased rapidly at low concentrations
until the growth became slower at higher concentrations. This behaviour has
also been reported for insulin and other amyloid systems using different detection
techniques [54, 138, 218]. It was suggested that not the attachment of precursor
proteins but a conformational rearrangement was the rate-limiting step at higher
concentration.
A prerequisite for correct on-rates determination by the surface-based SMR
measurements is that the elongation detection is not limited by analyte depletion in
the microfluidic system [33,88,240]. First, the transit time of the monomer solution
at the center of the 3 µm high and ca. 144 µm long microchannel was about 10 ms.




in the SMR microchannel was two
orders of magnitude smaller than in a typical SPR or QCM flow cell (ca. 50 µm high
and ca. 50 mm/s fast flow). This indicates a much faster diffusion from the center
of the channel to the wall. Here, vc is the velocity at the center of the channel, H is
the height of the channel and D is the diffusion coefficient that is 1.0 × 10−10 m2/s
for insulin. Furthermore, it took 4.57 s to have a monomer molecule bound to a
fibril. This long reaction time combined with the short diffusion time (22.5 ms)
resulted in a Damkohler number Da = 0.005 calculated by Da = time(diffusion)
time(reaction)
. The
Damkohler number was much smaller than 1, indicating that the detected binding
process was reaction-limited. As such, the transition from fast rate increase at low
concentrations to slow rate increase at high concentrations could only be explained
with the reaction mechanism.
The concentration-dependent kinetic data were then fitted with a two-step "dock
- lock" model , as illustrated in Figure 5.11:
M + F
kdock−−−→ F ∗ klock−−→ F
Since no dissociation was observed during the measurements, dissociation rate
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Figure 5.10: Kinetic measurements (a) and 3D-plot (b) of on-rates of seed fibrils at
various concentrations and temperature.
Figure 5.11: Schematic representation of a "dock-lock" model of insulin fibril elongation.
constants are assumed to be negligible for the fitting model. The fitting equation is










where NFibril is the product of surface density of the fibrils σFibril and the surface
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Table 5.1: Fitting parameters for the two-step "dock-lock" elongation mechanism.
T kdock klock
[◦C] [×103M−1s−1] [×10−2s−1]
20 0.92± 0.46 3.68± 0.56
25 1.40± 0.36 9.49± 1.21
32 3.60± 0.27 13.39± 0.45
37 4.33± 0.38 28.01± 0.56
42 21.12± 0.24 96.63± 3.57
area S. The surface density of the fibrils σFibril was 734 ± 89 molecules/µm2 as
presented in Section 5.2.1 and the surface area S was 5216 µm2 with the applied
SMR chip. Similar to Equation 5.1 in Section 5.1, the parameters N is the number
of the monomer molecules bound to the fibrils, and cMonomer is the concentration of
the monomer solution. In the microchannel, monomers attached to the fibril ends
loosely in the dock-step with apparent rate constant kdock, followed by the lock-step
of conformational rearrangement with the rate constant of klock. As introduced in
Section 1.1.2, the "dock-lock"-mechanism has been reported in previous studies
using diverse detection techniques, but the number of steps involved in the process
are still under debate. In this study, the two-step model can sufficiently describe
the data and models of greater complexity with more fitting parameters are not
necessary. The fitted rate constants for both dock and lock steps are listed in the
Table 5.1.
Furthermore, the rate constants of the dock and lock steps were found to follow
Arrhenius law, as expressed by equation 5.3, by plotting logarithms of the rate
constants as a function of inverse temperature (Figure 5.12).






The data points could be fitted well with a straight line. The activation energy EA
was determined from the slope of the fitted line. This activation energy represents
the enthalpic activation barrier ∆H‡ in the transition state theory. The values of
the activation energy were evaluated to be 27.8 ± 8.4 kcal/mol for the dock step
and 31.8± 5.2 kcal/mol for the lock step. Interestingly, the activation energy of the
lock step was only slightly higher than the energy of the dock step, indicating that
the lock step was the rate-limiting step of the elongation process. Therefore, the
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activation enthalpy of the elongation process was 31.8± 5.2 kcal/mol. Interestingly,
the revealed elongation enthalpy is equivalent to the bond energies of 4–15 hydrogen
bonds, since enthalpies of hydrogen bonds are in the range of 1.9–6.9 kcal/mol [73].
Following Knowles et al. [138], the Gibbs free energy of activation (∆G‡) can be
determined by using equation 5.4:







where R is the gas constant and Γ is a kinetic prefactor, which can be calculated
using equation 5.5 based on polymer theory on the basis of a simplified model for
amyloid fibril growth [31,138,146].
Γ = 103 ∗ cMonomer ∗NA ∗ rreac ∗ F ∗D (5.5)
Here, NA is the Avogadro number, rreac is the encounter volume on the order
of10−27 m3, D is the diffusion coefficient of insulin (1.0 × 10−10 m2/s), and F is the
fibril number per cm2 on the microchannel surface. In the SMR measurements,
the Gibbs free energy of activation was calculated to be 6.85 ± 0.85 kcal/mol for
elongation with 1 mg/mL monomer solutions at 25◦C. The entropic contribu-
tion of the activation T∆S‡ was determined to be 24.95 ± 6.05 kcal/mol using
∆G‡ = ∆H‡ − T∆S‡. The large entropy of activation may arise from unfolding of
proteins and release of bound water molecules.
Figure 5.12: Arrhenius plot of logarithms of the rate constants vs. inverse temperature
for the dock and lock steps of the elongation processes.
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Table 5.2: Thermodynamic parameters for amyloid-related proteins.
Protein Approach ∆H‡ or EA T∆S‡ (25◦C) ∆G‡
[kcal/mol] [kcal/mol] [kcal/mol]
Human insulin SMR 31.8± 5.2 25.0± 6.1 6.9± 0.9
Human insulin [170] QLS 25± 2 14.9± 0.6 8± 3
Bovine insulin [138] QCM 24.4± 1.0 16.8± 2.0 6.1± 2
Human Aβ [31] QCM 15.8± 1.9 14.4± 3.2 1.4± 1.0
Aβ [146] QLS 23.0± 0.6 ca. 16 ca. 7
The resultant thermodynamic parameters are generally comparable to the
literature values reported for different amyloid-related proteins using different
approaches, as listed in Table 5.2. Compared to the thermodynamic parameters
for human insulin detected by QLS in solution [170], the similar values in SMR
measurements suggest that the fibril elongation at the solid-liquid interface is
similar to the corresponding process in solution.
5.3.2 Shear Effect on Insulin Elongation Kinetics
Vigorous agitation or shaking has been reported to have a dominant effect on the
kinetics of amyloid fibril formation over other factors such as concentration and
ionic strength [15, 188, 261]. Moreover, protein solutions are often exposed to shear
stresses during bioprocessing steps including centrifugation, fractionation, pump-
ing and filtration [15, 167]. Although much experimental effort has been given to
understand the effects of shear flow on amyloid formation in solution, the uncon-
trolled shear stress under stirring and the heterogeneity of the resulting aggregation
products make it challenging to interpret results of conventional experiments to this
end [109,238]. In microfluidic systems, the small dimensions of the micrometer-sized
channels provide laminar flow at very high linear fluid velocities with low Reynolds
number and large shear stresses. Microfluidic platforms thus offer unique opportu-
nities to quantitatively study shear stress effects on amyloid elongation kinetics.
In surface-binding-based SMR measurements of this study, the elongation rates
of an ensemble of surface fibrils were compared at various shear rates by changing
the pressure between the two microchannel ends.
In microfluidic systems, the shear stress τ of Newtonian fluids in laminar flow is
proportional the dynamic viscosity of the fluid µ and to the velocity gradient in the
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Figure 5.13: Linear correlation of reciprocal of transit time and the pressure drop between
two microchannel ends (a) and measured frequency change rate for two different pressure
drops using SMR (b).





Here, y denotes the distance perpendicular to the boundary surface and u denotes
the flow velocity. In rectangular microchannels, the average shear stress τ̄ over the
perimeter of the channel and the Hagen-Poiseuille flow can be simply described using
the equations 5.7 and 5.8 with channel dimensions (height h, width w and length l),









Therefore, a linear correlation between the shear stress and the pressure drop is





The fluid flow inside the SMR microchannels was driven by applying pressure to
the inlets and outlets. In the 3 µm high and 8 µm wide resonator micorchannel, the
shear stress is thus theoretically in the range of (0.94–9.4)×10−3 bar when applying
a pressure drop of 0.025–0.25 bar. In conventional microfluidic channels, the typical
channel height is in the range of 5–100 µm and the width is 10–100 µm. By applying
0.001–0.01 bar pressure drop [82,165], the shear rates are normally one or two orders
of magnitude less than the shear rates in the SMR microchannels.
However, the shear stress or the flow velocity was difficult to predict accurately,
as the actual pressure drop could deviate from the theoretical value. Clogging,
partial clogging or minor obstruction of the channel could not be easily recognized
from the data. To this end, polystyrene beads were added to the 1 mg/mL monomer
solutions to trace the flow velocity by measuring the transit time. In the ca. 144 µm
long resonator channel, the average flow velocity uaverage of the parabolic velocity
profiles was then determined using uaverage = Lttransit with the transit time ttransit.
The average flow velocity is linearly proportional to the applied pressure drop.
The plot (a) of Figure 5.13 verifies that the flow velocity in the experiment
correlated linearly with the pressure drop as expected. However, the evaluation was
only done with pressure drop in the range of 0.025–0.25 bar. At higher pressure
drops, the transit time could not be resolved, since the beads passed too fast
through the resonator microchannel. However, the flow velocity could be roughly
estimated using the established calibration plotted in Figure 5.13 (a).
Furthermore, the elongation rates were compared with different pressure drops.
As shown in the plot (b) of Figure 5.13, the elongation rate with 0.02 bar pressure
drop was comparable to the rate with 0.18 bar pressure drop, indicating that a
9 times increase in pressure drop did not result in a significant change in elongation
rate. Previously, Hill et al. explored the shear stress effect on β-lactoglobulin fibril
elongation using a Couette cell combined with ThT-fluorescence detection [109].
They observed a rate increase with shear rate ranging from 50 to 200 s−1. The
shear rates in the SMR measurements were (2 − 20) × 104 s−1 with transit time of
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ca. 1–10 ms, which were 2–3 orders of magnitude higher than the shear rates in the
Couette cell experiments. It was suggested in some previous studies that a shear rate
of ca. 107 s−1 would be required to denature a small globular protein [15]. The shear
rates in SMR measurements were below this range. However, it is likely that the
shear stress effects on the elongation process have saturated in the SMR detection
range. Although with current microchannel dimensions and the pressure regulation
system the shear stress dependence of the amyloid elongation is below detection
limit, microfluidic systems with adequately designed channel dimensions and pres-
sure regulation in a lower range could be potential platforms for such measurements.
5.3.3 Influence of Additives on Elongation Kinetics
Specific chemical compounds can significantly affect the amyloid elongation process.
Screening techniques to search for inhibitors to prevent fibril growth are therefore
of importance for clinical applications. However, among the large variety of the
possible inhibitors which are summarized in Section 1.1.3, the inhibition effects
of many candidates remain under debate, since opposite conclusions have been
drawn by using different detection techniques [192, 279]. Here, selected candidates
from three categories (metal ions, natural products and small aromatic organic
compounds) were screened using SMR measurements. Additives were dissolved
in the 0.4 mg/mL monomer solutions at concentrations spanning several orders
of magnitude including the reported effective values. The elongation rates were
measured at 37◦C while successively introducing the monomer solutions with an
increasing concentration of the additives. In addition, two reference measurements
with the same monomer concentrations but without additives were carried out
before and after the additive measurements. In this way, more insight into inhibition
mechanisms can be given by knowing whether the inhibitors interact predominately
with monomers or with fibrils.
5.3.3.1 Kinetics with Additional Salt and Metal Ions
Four metal ion salts (NaCl, ZnCl2, MgCl2, CaCl2) were selected here to explore
effect on elongation kinetics. So far, their effect on the elongation kinetics have not
been completely revealed and understood.
Sodium chloride NaCl is frequently used as a component in buffer solutions.
Nielsen et al. studied the effect of ionic strength on insulin fibrillation kinetics using
the ThT-fluorescence assay and showed a slight decrease in lag time and in the
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apparent rate constants with increased NaCl concentration up to 50 mM [188].
Zn(II) ions have been reported to be able to inhibit insulin fibrillation at
physiological pH values by forming stable and soluble Zn(II)-insulin hexamer com-
plexes. The inhibitory effect has been suggested to be very strong at 3.5 µM at
pH 7.3 and become weaker at pH 5.5 [191]. Tougu et al. demonstrated that Zn(II)
inhibited the Aβ42 aggregation with IC50 value of 1.8 µM [249].
Additionally, MgCl2 and CaCl2 were tested due to their physiological relevance.
Mg(II) and Ca(II) are essential elements in the human body. While Ca(II) plays
an important role in signal transduction pathways, neurotransmitter release etc.,
Mg(II) is a relevant cofactor of numerous enzymes and is involved in the treatment
of many diseases including diabetes mellitus [100,164].
Figure 5.14 shows a summary of growth rates for different concentrations of all
four additives. The rates were normalized by the initial reference rates. In general,
no significant inhibition was observed with all four additives, indicating that all
the metal ions did not stabilize the monomer and fibril structures and suppress the
elongation process at the concentrations that were tested. Conversely, the additives
accelerated the elongation rates at some of the concentrations. The concentration
dependence of the growth rates of all the additives was similar. The rates increased
initially, reached the maximum at concentrations in the range of 60–100 mM and
decreased at higher concentrations. MgCl2 and CaCl2 showed a larger acceleration
effect than ZnCl2 and NaCl. However, mechanisms underlying the acceleration
effect of these additives have not been fully understood.
5.3.3.2 Kinetics with Additional Natural Products
Some microorganisms, e.g. hyperthermophiles, accumulate small stress molecules
as a means of surviving at temperatures higher than 100◦C [9]. This indicates
that small stress molecules may be able to stabilize the native conformation of pro-
teins. Arora et al. have reported that the small stress molecules ectoine, trehalose,
citrulline and betaine as natural products strongly suppressed insulin amyloid forma-
tion at concentrations as high as 300 mM [9]. In particular, ectoine was suggested to
inhibit the amyloid elongation. However, the results of SMR kinetic measurements
with ectoine and trehalose (30–300 mM) showed that both additives did not change
the elongation rates significantly.
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Figure 5.14: Test of elongation rates with additives of metal ions (NaCl, ZnCl2, MgCl2,
CaCl2). The screening procedure started with the initial injection of the 0.4 mg/ml
monomer solutions, followed by the injection of the monomer solutions with increased
additive concentrations and the final injection of the monomer solution.
5.3.3.3 Kinetics with Small Aromatic Organic Compounds
Small aromatic compounds have been reported as inhibitors of fibril forma-
tion [142, 158]. It has been suggested that the π-ring structure of the compounds
could interact with amyloids by stacking with the side chains or by hydrophobic
interaction. This could stabilize the fibrils or monomers and give rise to the anti-
aggregation potency by preventing the formation of complex β-sheet fibril structures.
Inhibition tests were carried out with two aromatic compounds: pthalocyanine
tetrasulfonate (PcTS) and methylene blue.
PcTS has been recently reported to efficiently reduce the pathogenic amyloid
deposits of tau protein using a combination of NMR and SAXS [5, 158]. The
inhibition experiments by Akoury et al. were conducted with PcTS concentrations
ranging from 200 pM to 200 µM, and the IC50 value was determined to be 1.25 µM.
In the SMR measurements, PcTS was added to the monomer solution at concentra-
tions ranging from 1 to 100 µM. As shown in Figure 5.16(a), a significant change
in elongation rates was only observed at high concentrations of 100 µM. However,
precipitation was also observed at this high concentration. At low concentrations
that are at or below the IC50, the rates were comparable to the reference solutions
without PcTS addition. The unchanged elongation rates of 0.4 mg/mL monomer
solutions before and after the injection of additive solutions (a, inset) indicate that
the aromatic PcTS compound did not interact with the surface fibrils.
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Figure 5.15: Test of elongation rates with additives of ectoine (a) and trehalose (b). The
screening procedure started with the initial injection of the 0.4 mg/ml monomer solutions,
followed by the injection of the monomer solutions with increased additive concentrations
and the final injection of the monomer solution.
Furthermore, the application of methylene blue has been suggested to be
able to attenuate amyloid plaques and slow down the progression of Alzheimer’s
disease [198]. Oz et al. showed in their experiments that the compound could inhibit
Aβ42 aggregation with an IC50 value of 2.3 µM. Here elongation rates were measured
with addition of methylene blue to the monomer solutions at concentrations of
1.25–125 µM. Figure 5.16 (b) shows that methylene blue had an inhibitory effect
on the elongation process. Under the experimental conditions, maximum impact
was found at low concentrations. Further tests need to be conducted to explore the
inhibition at low concentrations in more detail.
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Figure 5.16: Test of elongation rates with additives of PcTS (a) and methylene blue
(b). The screening procedure started with the initial injection of the 0.4 mg/mL monomer
solutions, followed by the injection of the monomer solutions with increasing additive con-
centrations and the final injection of the monomer solution. Insets show the frequency
monitoring of monomer solutions before (initial) and after (final) the injection of the solu-
tions with the two additives.
5.4 Dissociation Detection of Immobilized Insulin
Fibrils
In search of conditions and compounds that could break the stable fibrils into
monomers or short fragments, dissociation experiments were performed by
monitoring the rates of frequency change under various conditions. The tested
parameters were temperature, pH, and the same compounds that were used for
additive tests in Section 5.3.3.
The insulin fibrils on the channel surface were exposed to running buffers at
pH 2 and pH 7, respectively. Since fibrils were generally very stable on the surface
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at temperature higher than 37◦C (data not shown), the dissociation was detected
at temperatures ranging from 10–37◦C. After the temperature was changed, the
frequency measurement started after a new equilibrium was reached, which took
approximately 20 minutes. To exclude systematic errors due to the direction of
temperature change, the rates were measured after cooling down and heating up the
devices respectively. The temperature-dependence of fibril dissociation, as shown
in Figure 5.17, indicates that the dissociation rates were in general small (within
0.6 Hz/min). The rates were not much different from the background signal,
indicating that fibrils are relatively stable. However, it was also observable that
the fibrils dissociated slightly faster with decreased temperature. This observation
is in agreement with previous studies, which suggested that amyloid fibrils are
highly sensitive to low temperature [135]. There was no significant difference in
dissociation rates between pH 2 and pH 7, showing that pH values had a minor
effect on fibril stability.
Furthermore, the dissociation measurements were performed by loading the
buffer solutions with additives of metal ions (NaCl, ZnCl2, MgCl2, CaCl2), natural
products (ectoine, trehalose) and small organic molecules (PcTS, methylene blue) at
pH 2 and 37◦Cinto the microchannel with fibrils on the surface. The reference signal
was obtained by measuring the frequency shift when buffer without additives was
in the channel. All measured dissociation rates were comparable to the reference
value of ca. -0.158 ± 0.07 Hz/min, implying that the tested compounds were not
able to degrade stable fibrils.
In conclusion, although ideal candidates to dissociate fibrils have not been found
in the dissociation experiment, the surface-binding based SMR method is demon-
strated to be a reliable platform for the screening of potential drugs to dissolve fibrils.
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Figure 5.17: Dissociation monitoring of insulin fibrils at pH 2 (a) and pH 7 (b). Time
courses of the dissociation monitoring at various temperatures with buffer solutions at
pH 7 (c).
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Chapter 6
Conclusions
This thesis demonstrates a novel microfluidic approach using SMR devices to
quantitatively study the kinetics of amyloid growth by mass. Amyloid formation
consists of many elementary steps including the formation of seeds by nucleation
and subsequent elongation to mature insoluble fibrils. In the surface-based SMR
measurements, short amyloid seed fibrils are immobilized on the microchannel
surfaces, and the elongation rates as well as the rate constants are determined by
monitoring the mass change of the fibril ensemble over time. Using insulin as a
model, comprehensive experimental data sets of measured fibril elongation kinetics
shed light on the thermodynamic parameters and the underlying mechanisms
that govern this process. Compared to conventional dye-binding assays in bulk
solutions, such as ThT-fluorescence, the label-free method is sensitive to all states
of the aggregation, avoids the risk of interfering with the reaction, and enables
accurate rate constant determination independent of the stoichiometry of the dye
binding. Compared to current biosensor techniques, the microfluidic trasducer
system achieves further miniaturization of the detection devices with higher mass
resolution.
Reliable immobilization of seed fibrils on the surface of closed microchannels is
the basis for accurate kinetic measurements. Since the surfaces of SMR devices
employed in this study are not transparent, reliable immobilization techniques have
been developed in transparent microchannel systems and are later transferred to the
SMR. Electrostatic interaction using PLL and covalent coupling using aminosilane
and glutaraldehyde have been compared and the bio-functionality of the seed fibrils
has also been tested. Stability and kinetic reproducibility tests have revealed that
only covalently immobilized fibrils are sufficiently stable inside the microchannel
for quantitative elongation rate measurements. Furthermore, covalent coupling
is superior to the electrostatic PLL-linking due to lower non-specific adsorption
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of proteins after passivating the reactive functional groups. Therefore, covalent
coupling has been applied for all kinetic measurements in this thesis.
The robust covalent protein coupling on the microchannel surface consists of
multiple steps, each of which is quantitatively validated:
First, vapor phase deposition of aminosilanes has been successfully developed
to functionalize the surfaces of closed microchannel systems with reactive amine
groups. The method overcomes numerous challenges associated with the microfluidic
environment such as cross-contamination of reagents by dispersion and clogging.
The generated amine functional layers are uniform, stable and can be regenerated
reproducibly. The applied deposition method furthermore allows batch fabrica-
tion of microchannels with functional groups. All these features have been assessed
using a novel method that allows quantitative fluorescence-based imaging of surface
functional groups inside assembled micro- and nanochannels.
Difficulties in fluorescence quantification of surface functional groups have been
recognized by observing the opposing effect of photobleaching and self-quenching
due to the dense packing of fluorophors. The use of competitive labeling with
stable fluorescent and non-fluorescent molecules eliminates the complexity of self-
quenching and results in excellent linearity between the area density of functional
groups and fluorescence intensity. Reactive amine groups with a surface density of
55 ± 9 pmol/mm2 are reproducibly generated by vapor deposition using ATPMS
for 16 h at 80◦C.
Subsequently, glutaraldehyde has been used to further functionalize surface
amine groups with aldehyde groups, which couple to amine groups of proteins
by Schiff’s base formation, followed by the use of a reduction agent to stabilize
the labile bonds. To characterize protein binding capacity, GFP moleucles are
immobilized on the surface, revealing a packing density of 1.2 ± 0.5 pmol/mm2.
Uniform seed fibrils of 97.6 ± 20.1 nm as validated by EM are prepared and
immobilized in the SMR. Based on the size of seeds measured by EM and the
total mass of the immobilized layer, the surface density of immobilized seed fibrils
has been determined to be 734 ± 89 molecules/µm2 with fibril-fibril distance of
37 ± 13 nm. This has also been validated using AFM.
Upon completion of the development and characterization of the detection
platform, the kinetics of insulin seed fibril formation have been systematically
explored. In agreement with the theory that amyloid elongation is a bimolecular
reaction, the SMR measurements show a continuous linear fibril growth at a rate
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that a monomer on average binds to a fibril every 4.9 ± 0.5 s, corresponding to
the rate constant of (1.2± 0.1)× 103 M−1 s−1, in a 1 mg/mL monomer solution at
37◦C. This result is comparable with reported literature values detected by QCM.
To systematically study the impact of monomer concentration and temperature
on the elongation kinetics of amyloid fibrils, a large number of elongation rates
have been measured under various conditions. A temperature reduction from 37◦C
to 25◦C results in a 3.5 times decrease in elongation rate, and the concentration-
dependence of the elongation rates is non-linear, showing a rapid increase at low
monomer concentrations and a slow increase at high concentrations. This non-linear
behaviour has been modeled with a two-step "dock-lock"-mechanism, by which a
conformational change of the lock-step is the rate-limiting step of the process. Ther-
modynamic parameters have also been obtained from the data, showing that fibril
elongation is in general enhalpically unfavorable but entropically favorable. The
detected enthalpy of activation from the SMR measurements, 31.8 ± 5.2 kcal/mol,
is comparable with the reported values for insulin and other amyloid pro-
teins measured by QCM and QLS, suggesting that this order of magnitude could
be characteristic for the activation energy of amyloid elongation processes in general.
Finally, the surface-based SMR detection has been applied to explore the effects
of environmental factors such as shear stress, metal ions, natural products and
small organic compounds. Shear rate, generated by applying a pressure drop of
0.025–0.25 bar in this study, has been proved to have no measurable impact on the
elongation rate, likely because the shear stress effects on the elongation process have
saturated with high shear rates in SMR detection. By comparing the elongation rates
with the reference monomer solution without additives on the identical fibril ensem-
ble, it has been found that metal ion additives (NaCl, MgCl2, CaCl2 and ZnCl2)
generally accelerate the elongation at concentrations in the range of 60–100 mM.
Natural products (ectoine and trehalose) do not change the rates. PcTS inhibits the
elongation at high concentration of 200 µM while methylene blue slows down the
elongations at low concentrations.
The mechanisms behind the effects of additives on the elongation kinetics have
not been fully studied in this thesis and need to be addressed in further work.
However, this approach has shown its capability and potential of searching for
therapeutic drugs for amyloid-related diseases.
In addition, dissociation of the immobilized fibrils off the microchannel surface
has been monitored under various conditions (pH, temperature and addition of
the compounds applied in the association tests). It has been found that pH and
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the selected additives do not efficiently degrade the stable fibrils. It has been
observed that lowering temperature slightly increases the fibril dissociation rates,
although these rates are not much different from the background signal. In general,
the dissociation monitoring is suggested to be a promising in situ approach for
screening of potential fibril degradation candidates.
Another important future goal is to study early aggregation events by surface-
based SMR measurements. In the current study, kinetic measurements with
immobilized monomers instead of seed fibrils on the microchannel surface do not
show significant signals of early nucleation processes, possibly due to the detection
limit of the system or low binding capacity using the current immobilization
techniques. This may be improved by a new generation of SMR devices with
smaller microchannel dimensions and higher sensitivity. In addition, much effort
will be given to optimize the immobilization techniques so that binding capacity of
monomers can be maximized.
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Table 6.1: Fitting parameters for time-dependent fluorescence detection[1].
Parameter 1.25 µM 2.5 µM 3.5 µM 5 µM 10 µM 20 µM 40 µM 5 µM pure 10 µM pure
A1 2200 3130 7187 12194 18010 24142 33971 16099 16949
τph1 4272 7413 7472 5147 4937 7451 6735 8733 8677
A2 403 1378 1831 0 0 0 0 0 0
τph2 247 704 802 NA NA NA NA NA NA
A3 0 0 0 0.031 0.105 0.251 0.344 0.565 0.584
τdequench NA NA NA 34 106 149 213 182 133
Adj. R-square 0.9979 0.9986 0.9969 0.9850 0.9867 0.9946 0.9916 0.9881 0.9722
1











Table 6.2: Standard statistical errors for fitting parameters[1].
Error 1.25 µM 2.5 µM 3.5 µM 5 µM 10 µM 20 µM 40 µM 5 µM pure 10 µM pure
A1 16 78 277 68 134 74 152 102 127
τph1 60 415 608 87 95 81 93 181 285
A2 17 73 264 0 0 0 0 0 0
τph2 23 48 130 NA NA NA NA NA NA
A3 0 0 0 0.019 0.013 0.005 0.005 0.013 0.012
τdequench NA NA NA 40 28 6 8 9 6
1
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